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Abstract: Vitamin K is crucial for many physiological processes such as coagulation, energy
metabolism, and arterial calcification prevention due to its involvement in the activation of several
vitamin K-dependent proteins. During this activation, vitamin K is converted into vitamin K epoxide,
which must be re-reduced by the VKORC1 enzyme. Various VKORC1 mutations have been described
in humans. While these mutations have been widely associated with anticoagulant resistance, their
association with a modification of vitamin K status due to a modification of the enzyme efficiency has
never been considered. Using animal models with different Vkorc1 mutations receiving a standard diet
or a menadione-deficient diet, we investigated this association by measuring different markers of the
vitamin K status. Each mutation dramatically affected vitamin K recycling efficiency. This decrease
in recycling was associated with a significant alteration of the vitamin K status, even when animals
were fed a menadione-enriched diet suggesting a loss of vitamin K from the cycle due to the presence
of the Vkorc1 mutation. This change in vitamin K status resulted in clinical modifications in mutated
rats only when animals receive a limited vitamin K intake totally consistent with the capacity of each
strain to recycle vitamin K.
Keywords: vitamin K epoxide reductase; vitamin K status; mutation; osteocalcin
1. Introduction
K vitamins are a complex family composed of several similarly fat-soluble molecules having a
2-methyl-1,4-napthoquinone ring in common. The different forms of vitamin K are distinguished
according to the length and nature of the carbon chain in position 3 of the naphthoquinone ring [1].
Vitamin K1 or phylloquinone contains a phytyl side chain, which comprises 4 prenyl units. Vitamin
K1 is synthesized only by plants, green algae, and some cyanobacteria and is, thus, found mainly in
green vegetables. Vitamins K2 or menaquinones (MK) contain an unsaturated aliphatic side chain
with a variable number of prenyl units. Depending on the number of prenyl units, vitamins K2 can be
divided into different short-chain MK (i.e., mainly menaquinone-4, MK-4) found mainly in meat and
fermented foods and long chain MKs mainly of bacterial origin (i.e., MK-7, to MK-14).
Vitamin K is important for many physiological processes as the cofactor of the gamma-glutamyl
carboxylase (GGCX) enzyme [2,3]. This enzyme is involved in the activation of many proteins, called
vitamin K-dependent proteins (VKDPs), by catalyzing their γ-glutamyl carboxylation. Vitamin K
is, thus, crucial for blood coagulation through the activation of hepatic blood clotting factors II, VII,
IX, and X. Vitamin K is also essential for energy metabolism and arterial calcification prevention
through the activation of osteocalcin [4] and Matrix Gla Protein [5], respectively, which are both
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extrahepatic VKDPs. It was also described to be involved in bone metabolism [6,7], cancer progression,
inflammatory response [8], oxidative stress [9], shingolipids synthesis [10], and pancreas exocrine
activity [11].
Recommended vitamin K intake in a normal healthy adult varies from 50 to 600 µg/day for vitamin
K1, and from 5 to 600 µg/day for vitamin K2 [12]. This recommended vitamin K intake is only based on
blood coagulation and varies according to the region. Common polymorphisms or mutations in certain
key genes involved in vitamin K metabolism might affect nutritional requirements. Nevertheless, this
evidence is indirect via effects on warfarin dose requirements and direct demonstrations are missing.
During gamma-carboxylation of VKDP, vitamin K is converted into vitamin K epoxide by GGCX [2].
The latter is then re-reduced first into vitamin K quinone and then into vitamin K hydroquinone by
the vitamin K epoxide reductase (VKORC1) enzyme to be reusable for a new activation of VKDP. It is
estimated that one molecule of vitamin K can be used up to 500 times by GGCX [13]. Inhibition of the
VKORC1 by vitamin K antagonists such as warfarin leads to inhibition of recycling, which results in a
hemorrhage due to a deficiency of activated clotting factors II, VII, IX, and X. This is indicative of the
central role played by VKORC1 in the low vitamin K requirement, and any change in this activity may
lead to an increased or decreased vitamin K requirement [14].
Various polymorphisms and mutations of the VKORC1 gene have been described in humans.
Five common non-coding polymorphisms of the VKORC1 gene located in the promoter region, in the
first and second intron, and in the 3′ downstream region described in patients requiring increased
doses of vitamin K antagonists are associated with reduced expression of VKORC1 [15]. More
than 30 mutations in the coding region of VKORC1 have also been described in patients requiring
increased doses of anticoagulants [16–20]. While these mutations have been widely suspected of
causing anticoagulant resistance, their association with an increase in the vitamin K requirement due
to a modification of the enzyme efficiency has rarely been considered [21].
Vkorc1 mutations are also widespread in other animal species, particularly rats and mice whose
populations are managed with vitamin K antagonists [22]. Recently, characterization of an animal
model of rats carrying a Vkorc1 mutation in the coding region leading to the Y139C mutation has
demonstrated that the latter fed with a vitamin K3 deficient diet, which is a synthetic vitamin K
normally widely present in rodent diets, presented arterial media calcification [23]. These calcifications
were shown to be associated with a gamma-carboxylation defect of Matrix Gla Protein (MGP) involved
in the vascular calcification prevention. This gamma-carboxylation defect could be due to a decrease
in the efficiency of VKORC1 activity. This work aims to compare the vitamin K status in different rats
carrying different mutations of the Vkorc1 gene in order to evaluate the impact of such mutations and
the influence of the nature of the mutations on the vitamin K status and, therefore, on the vitamin
K requirement.
2. Materials and Methods
2.1. Animals
Rats homozygous for Y139C-Vkorc1, rats homozygous for Y139F-Vkorc1, and rats homozygous
for L120Q-Vkorc1 were derived from back-crossings and inter-crossings between laboratory
Sprague-Dawley rats (designed as recipient strain) (Charles River, St Germain sur l’Arbresles, France)
and wild rats homozygous for Y139C-Vkorc1, Y139F-Vkorc1, or L120Q-Vkorc1 (designed as a donor strain
for the Vkorc1 mutation). Wild rat strain, carrying the Y139C mutation in Vkorc1 at the homozygous
state, was a generous gift from Julius Kuhn Institute [23]. A wild rat strain carrying the Y139F
mutation in Vkorc1 at the homozygous state was initially trapped on French farms in the 1980s and
have since been maintained at the Lyon College of Veterinary Medicine, France [24]. Berkshire rats
homozygous for Q120 in the Vkorc1 were a generous gift from U.K.-based Sorex Ltd., Widnes, Great
Britain. The founder animals of this strain were initially trapped in an English farm in the Berkshire
countryside [25,26].
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To form congenic strains, male wild rats homozygous for Y139C-Vkorc1, Y139F-Vkorc1, or
L120Q-Vkorc1 were crossed with Sprague-Dawley females to create the F1 hybrid generation,
respectively. The F1 heterozygous for the Y139C-Vkorc1, Y139F-Vkorc1, or L120Q-Vkorc1 mutation
males were backcrossed to Sprague-Dawley females to give the F2 generation. The genotype of F2
young rats was determined by the allele-specific PCR method, as described by References [23,24,26].
Heterozygous females were back-crossed to the recipient Sprague-Dawley strain for 18 additional
generations yielding F20 generation. Lastly, an F20 intercross of males heterozygous for Y139C-Vkorc1,
Y139F-Vkorc1, or L120Q-Vkorc1 with females heterozygous for Y139C-Vkorc1, Y139F-Vkorc1, or
L120Q-Vkorc1, respectively, was carried out to obtain F20-introgressed rats homozygous for
Y139C-Vkorc1, Y139F-Vkorc1, or L120Q-Vkorc1 [23,24,26].
Animals were kept in standard cages (Eurostandard, Type IV, Tecniplast, Limonest, France), and
received standard feed (Scientific Animal Food and Engineering, reference A04) and water ad libitum.
2.2. Animal Treatment
Experimental research on the rats was performed according to an experimental protocol following
international guidelines and with approval from the ethic committee of the Veterinary School of Lyon
(authorization n◦2017041910166230).
During vitamin K deficiency experiments, eight-week-old male rats received for a maximum
of 12 days a diet deficient in vitamin K3 (menadione) without barley (Scientific Animal Food and
Engineering, SAFE A04 v231) (designed in this study as diet-K3) ad libitum. This diet was composed of
corn starch 36.1% (instead of barley rich in vitamin K1), wheat 25%, corn 15%, wheat bran 5%, peanut
oil 3%, soybean meal 8%, fish hydrolyzate 4%, and minerals/vitamins mix 3.9% (without vitamin
K3). Concentrations of vitamin K1 and K3 were determined by the supplier and were under the limit
of quantification.
Rats were killed 0, 4, 8, or 12 days after the beginning of the feeding period with the special diet
-K3 with CO2. The organs (liver, kidney, lung, heart, and testis) of each rat were immediately collected
and stored at −20 ◦C.
2.3. Preparation of Liver Microsomes
Microsomes were prepared from fresh organs by differential centrifugation, as described by
Reference [27]. Livers, lungs, kidneys, and testis of rats fed with a standard diet were resuspended
in 50 mM phosphate buffer (pH 7.4) containing 1.15% (w/v) of KCl. Organ cells were broken and
homogenized in buffer by using a motor driven Potter glass homogenizer and further submitted to
differential centrifugation at 4 ◦C. The 100,000 g pellet corresponding to the membrane fraction was
resuspended by Potter homogenization in HEPES glycerol buffer (50 mM HEPES, 20% glycerol, pH 7.4).
Protein concentrations were evaluated by the method of Bradford [28] using bovine serum albumin as
standard microsomes were frozen at −80 ◦C and used for kinetic analysis and ELISA kits.
2.4. Vitamin K Epoxide Reductase Activity (VKOR) Assays and Kinetics
Microsomal vitamin K epoxide reductase (VKOR) activity was assayed as described previously [29].
Standard reactions were performed in 200 mM Hepes buffer (pH 7.4) containing 150 mM KCl, 1 mM
dithiothreitol, and 1 g.L-1 of total proteins. The reaction was started by the addition of vit K1 > O
solution in 1% Triton X-100 and incubated at 37 ◦C for 30 min. In these conditions, the reaction was
linear, according to the time of incubation and the quantity of incubated proteins. After incubation at
37 ◦C for 30 min, the reaction was stopped by adding 2 mL of isopropanol. After centrifugation at
3000× g for 10 min in order to precipitate proteins, 2 mL of hexane was added. After centrifugation
at 3000× g for 10 min, the hexane layer was removed and dried under nitrogen. The dry residue
was immediately dissolved in 0.2 mL of methanol and the reaction product was analyzed by liquid
chromatography-mass spectrometry [29].
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2.5. VKORC1 and VKORC1L1 ELISA Quantitative Assays
The VKORC1 protein was quantified from liver, testis, kidney, and lung microsomes using the “Rat
Vitamin K epoxide reductase complex subunit 1” ELISA kit (Cliniscience, Nanterre, France), according to
the manufacturer’s recommendations. The VKORC1L1 protein was quantified from liver, testis, kidney,
and lung microsomes using the “Rat Vitamin K epoxide reductase complex Subunit 1-Like Protein 1”
ELISA kit (Cliniscience, Nanterre, France), according to the manufacturer’s recommendations.
2.6. Measurement of Vitamin K Concentrations
Furthermore, 0.5 g of tissue was homogenized with ethanol 33% using an Ultra Turrax tissue
disperser from IKA Labortechnick® (VWR International, Strasbourg, France and then extracted with
4 mL of hexane. After centrifugation at 3000 rpm for 5 min at 4 ◦C, the supernatant was collected and
extracted again with 4 mL of hexane. After centrifugation at 3000 rpm for 5 min at 4 ◦C, the supernatant
was collected and evaporated at 37 ◦C to dryness under a gentle stream of nitrogen. The final dry
extract was dissolved in 500 µL of methanol and vitamins K (i.e., Menaquinone 4-MK4-, Menaquinone
4 epoxide-epoxide -K1OX-) were analyzed by HPLC on reverse phase C18 column (4.6 × 100 MK4OX-,
phylloquinone -K1-, phylloquinone mm, 2.7 µm, VWR, Fontenay-sous-bois, France). A post-column
reactor (2.1 × 50 mm steel column packed with zinc powder) was connected in series between the
analytical column and detector to ensure the reduction of K vitamins and allow the detection of
reduced K vitamins by fluorescence with excitation and emission wavelengths of 246 and 430 nm,
respectively. A gradient elution system was used with a flow rate of 1 mL/min as follows. After 24 min
of elution with 99% methanol/1% water (acidified with 1% acetic acid containing 1.1 g.L−1 of zinc
acetate), the mobile phase was quickly changed from 99% methanol/1% water (acidified with 1% acetic
acid containing 1.1 g.l−1 of zinc acetate) to 50% methanol/49% dichloromethane with 1% acetic acid
and 1.1 g.l−1 of zinc acetate in 0.1 min. Under these HPLC conditions, MK4OX, MK4, K1OX, and K1
were eluted at 7.5 min, 10.3 min, 12.5 min, and 18.8 min, respectively.
2.7. Undercarboxylated Osteocalcin (ucOC) and Undercarboxylated Matrix Gla Protein (ucMGP) ELISA
Quantitative Assays
The ucOC concentration was quantified in plasma by ELISA using the “Rat Glu-osteocalcin High
Sensitive EIA” kit (Ozyme, Saint Cyr l’école, France), according to the manufacturer’s recommendations.
2.8. Tissue Calcium Measurement
Tissues were placed in an oven at 50 ◦C for 72 h and then reduced to a powder using a glass
mortar. Calcium was extracted from 10 to 50 mg of tissue powder (depending on the organs) in
200 µL to 1 mL of a 10% formic acid solution for at least 2 h. The supernatant was recovered after
centrifugation at 3000× g for 10 min and then evaporated at 110 ◦C. Residues were resuspended with
mili-Q water corresponding to half of the volume of the formic acid solution. Calcium was assayed
using the calcium colorimetric assay kit (Sigma-Aldrich, l’Isle d’Abeau, Chesnes, France), according to
the manufacturer’s recommendations.
2.9. Data Analysis
Km and Vmax values were obtained from at least four separate experiments performed on
four different batches of protein. The estimation of Km and Vmax values was achieved by the
incubation of at least nine different concentrations of vit K > O (from 0.003 to 0.2 mM) to the standard
reaction. Incubations were performed in duplicate. Data were fitted by nonlinear regression to the
Michaelis-Menten model using the R-fit program.
Data are presented as the mean ± SD. Statistical analysis was done by using the Tukey’s multiple
comparisons test or the Dunn’s multiple comparisons tests, and using GraphPad Prism 6 software
(GraphPad, San Diego, CA, USA). p < 0.05 was the accepted level of significance.
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3. Results
3.1. Tissue VKOR Activity in Rats According to Vkorc1 Genotype
3.1.1. Kinetics Parameters of VKOR Activity
To evaluate the influence of the Vkorc1 genotype on the ability to recycle vitamin K epoxide in
vitamin K quinone between rat tissues, liver, kidney, testis, and lung microsomes from male rats with a
different Vkorc1 genotype (i.e., homozygous for wild type, Y139C, Y139F, or L120Q) were prepared.
Catalytic properties of the VKOR activity measured in these microsomes were determined. Km and
Vmax results are presented in Table 1. For all strains, VKOR activity was higher in liver, then in testis,
then in kidneys, and then in lungs. Statistical differences were found between strains only concerning
the Vmax value. The Vmax value of VKOR activity in liver of rats belonging to the wild type (WT)
strain was, respectively, 4.1, 2.8, and 2.8-fold higher than that of rats belonging to L120Q, Y139F, and
Y139C strains. The Vmax value of VKOR activity in the testis of rats belonging to the WT strain was,
respectively, 6.0, 6.0, and 3.1-fold higher than that of rats belonging to L120Q, Y139F, and Y139C strains.
The Vmax value of VKOR activity in the kidney of rats belonging to the WT strain was, respectively,
4.2, 4.0, and 2.3-fold higher than that of rats belonging to L120Q, Y139F, and Y139C strains. In lungs,
VKOR activity was similar between strains.
Table 1. Kinetics parameters of VKOR (Vitamin K epoxide reductase) activity and ratio between
VKORC1 and VKORC1L1 proteins in different rat tissues according to the Vkorc1 genotype. Results are
the mean of four independent determinations with its 95% confidence interval.
Tissue Strain Km (µM) Vmax (pmol.min−1.mg−1) Vmax/Km(µL.min−1.mg−1)
Liver
WT 29.58 [18.96–40.21] 95.62 a,b,c [84.13–107.1] 3.2 a,b,c [2.2–4.2]
L120Q 37.98 [20.45–55.52] 22.18 a,d,e [18.45–25.91] 0.6 a [0.4–0.8]
Y139F 22.52 a [14.49–30.56] 34.50 b,e [30.62–38.39] 1.6 b [1.3–1.9]
Testis
Y139C 46.89 a [30.64–53.13] 34.52 c,d [29.97–39.07] 0.8 c [0.5–1.1]
WT 9.92 [4.00–15.84] 53.26 a,b,c [45.03–61.49] 5.5 a,b,c [5.3–5.7]
L120Q 16.70 [11.18–22.22] 8.94 a,d [8.08–9.79] 0.5 a [0.4–0.6]
Y139F 5.43 [2.31–8.55] 8.86 b,e [6.53–11.19] 1.2 b [0.6–1.8]
Y139C 12.35 [3.55–21.15] 17.05 c,d,e [12.11–21.99] 1.4 c [1.0–1.8]
Kidney
WT 12.12 [3.79–20.45] 20.39 a,b,c [15.42–25.36] 1.7 a,b [1.0–2.4]
L120Q 23.32 [19.80–26.84] 4.82 a,d [4.59–5.05] 0.2a [0.1–0.3]
Y139F 12.25 [1.48–23.03] 5.11 b,e [3.89–6.32] 0.5 [0.1–0.9]
Y139C 23.24 [4.98–41.5] 8.67 c,d,e [6.06–11.28] 0.4b [0.2–0.6]
Lung
WT 13.16 [6.017–20.29] 6.53 a,b [5.56–7.51] 0.5 [0.2–0.8]
L120Q 19.24 [14.84–23.63] 3.94 a,c [3.67–4.21] 0.20 [0.1–0.3]
Y139F 10.03 [3.4–16.66] 4.11 b [2.87–5.35] 0.4 [0.2–0.6]
Y139C 15.78 [3.06–28.50] 6.43 c [4.59–8.26] 0.4 [0.2–0.6]
p < 0.05 was the accepted level of significance. a, b, c, d, e statistical difference between the two groups. WT:
wild type.
3.1.2. Ratio Between VKORC1 and VKORC1L1 Enzymes
Because two different proteins, VKORC1 and VKORC1L1, may be involved in the reduction of
vitamin K epoxide in vitamin K quinone, concentrations of both enzymes in liver, testis, kidneys,
and lungs were determined by ELISA (Enzyme-linked immunoabsorbent assay) quantitative assays.
The results are presented in Table 2. No statistical difference for the ration between VKORC1 and
VKORC1L1 was observed between strains. In liver, whatever the strain considered, the concentration
of the VKORC1 protein was always much higher than that of the VKORC1L1 protein with no statistical
difference between strains except for the Y139F strain for which VKORC1 was 1.5-fold higher than
that of the WT strain. In other tissues, concentrations of VKORC1 and VKORC1L1 proteins were
comparable with the VKORC1 protein, which is slightly more present than the VKORC1L1 protein
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in testis and lung. This is the opposite in the kidney. In the lung, VKORC1L1 expression was 1.5 to
1.9-fold greater in mutant strains when compared to the WT strain.
Table 2. VKORC1 and VKORC1L1 concentrations and ratio between VKORC1 and VKORC1L1
proteins in different rat tissues according to the Vkorc1 genotype. Results are the mean of 4 independent
determinations with its standard deviation.
Tissue Strain
VKORC1
(µg/g of Tissue)
VKORC1L1
(µg/g of Tissue)
[VKORC1 Protein]
[VKORC1L1 Protein]
Liver
WT 4.44 ± 0.97 0.27 ± 0.04 16.2 ± 1.7
L120Q 2.66 ± 0.38 0.19 ± 0.03 14.0 ± 1.4
Y139F 7.13 ± 2.30 * 0.43 ± 0.13 17.6 ± 5.7
Y139C 4.31 ± 0.80 0.30 ± 0.05 14.4 ± 2.2
Testis
WT 0.25 ± 0.07 0.19 ± 0.04 1.4 ± 0.5
L120Q 0.35 ± 0.08 0.21 ± 0.09 1.6 ± 0.5
Y139F 0.24 ± 0.10 0.22 ± 0.02 1.1 ± 0.5
Y139C 0.27 ± 0.06 0.21 ± 0.04 1.3 ± 0.3
Kidney
WT 0.10 ± 0.03 0.18 ± 0.02 0.54 ± 0.14
L120Q 0.14 ± 0.02 0.17 ± 0.01 0.82 ± 0.13
Y139F 0.08 ± 0.04 0.23 ± 0.02 0.33 ± 0.19
Y139C 0.12 ± 0.01 0.18 ± 0.01 0.67 ± 0.06
Lung
WT 1.25 ± 0.12 0.70 ± 0.06 1.8 ± 0.2
L120Q 1.25 ± 0.22 1.35 ± 0.22 * 0.9 ± 0.2
Y139F 1.83 ± 0.54 1.22 ± 0.11 * 1.5 ± 0.2
Y139C 1.23 ± 0.19 1.10 ± 0.04 * 1.1 ± 0.2
* p < 0.05 was the accepted level of significance compared to the WT strain.
3.2. Vitamin K Status According to the Vkorc1 Genotype in Rats fed with a Standard Rodent Diet
3.2.1. Vitamin K Concentrations
To evaluate the influence of the Vkorc1 genotype on the vitamin K status, concentrations of vitamin
K1, K1OX, MK4, and MK4OX were determined in liver, testis, kidneys, and lungs of rats homozygous
for wild type, Y139C, Y139F, or L120Q fed with a standard rodent diet. Vitamin K1 and K1OX were
almost undetectable in all the considered tissues, whatever the genotype of rats. Only MK4 and
MK4OX were, therefore, quantified. Results are presented in Figure 1. Statistic differences were found
between strains only concerning the concentration of MK4.
Whatever the tissues considered, MK4 concentration was systematically higher in rats homozygous
for wild type Vkorc1 compared with rats homozygous for Y139F-KORC1 or Y139C- KORC1. In liver, it
was 1.5-fold and 2.4-fold higher. In testis, it was 1.7-fold and 2.1-fold higher and, in kidneys, it was
1.9-fold and 2.6-fold higher. In the lung, it was 2.7-fold and 2.8-fold higher when compared with rats
homozygous for Y139F-Vkorc1 or Y139C-Vkorc1, respectively.
In liver and testis, MK4 concentration was similar between wild type rats and rats homozygous
for L120Q, while it was 1.9-fold higher in lungs and kidneys of wild type rats compared with rats
homozygous for L120Q.
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homozygous for WT-, L120Q-, Y139C-, or Y139F-Vkorc1 fed with a standard rodent diet. The box 
extends from the 25th to 75th percentiles and the line corresponds to the mean. Statistical 
analyses were performed using a Tukey’s multiple comparisons test. p < 0.05 was the accepted 
level of significance. a,b,c,d,e, statistical difference between 2 groups. 
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Under-gamma carboxylated osteocalcin (ucOC) and matrix Gla protein (ucMGP) concentration 
was measured in plasma of rats homozygous for wild type, Y139C, Y139F, or L120Q fed with a 
standard rodent diet. Results for ucOC are presented in Figure 2. Statistical differences were found 
only for ucOC concentration between wild type rats and rats homozygous for Y139C and Y139F. 
UcOC concentration was 6.1-fold and 7.0-fold higher in the plasma of rats homozygous for Y139F- 
and Y139C-Vkorc1, respectively, compared with wild type rats. A difference between wild type rats 
and rats homozygous for L120Q was not statistically significant. 
Figure 1. Vitamins K concentrations in (A)/liver, (B)/testis, (C)/kidney, and (D)/lung of rats homozygous
for WT-, L120Q-, Y139C-, or Y139F-Vkorc1 fed with a standard rodent diet. The box extends from the
25th to 75th percentiles and the line corresponds to the mean. Statistical analyses were performed using
a Tukey’s multiple comparisons test. p < 0.05 was the accepted level of significance. a,b,c,d,e, statistical
difference between 2 groups.
3.2.2. Plasma ucOC Concentration
Under-gamma carboxylated osteocalcin (ucOC) and matrix Gla protein (ucMGP) concentration
was measured in plasma of r ts homozygous for wild type, Y139C, Y139F, or L120Q fed with a s andard
rodent diet. Results for ucOC are presented in Figu e 2. Statistical differences were found only for ucOC
co centration between wild type rats and rats homozygous fo Y139C and Y139F. UcOC conc ntration
was 6.1-fold and 7.0-fold higher in the plasma of rats homozygous for Y139F- and Y139C-Vkorc1,
respectively, compared with wi type rats. A differ nce between wild type rats and rats homozygous
for L 20Q was not statistically significant.
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Figure 3. Tissue calcium content in (A) testis, (B) kidney, (C) lung, and (D) heart of rats homozygous 
for WT-, L120Q, Y139C or Y139F-VKORC1 fed with a standard rodent diet. The box extends from the 
25th to 75th percentiles and the line corresponds to the mean. Statistical analyses were performed 
using a Dunn’s multiple comparisons test. 
3.3. Evolution of the Vitamin K Status According to the Vkorc1 Genotype in Rats Receiving a Specific Diet-
K3 for 12 Days 
3.3.1. Vitamin K Concentrations 
Figure 2. ucOC concentrations in the plasma of rats homozygous for WT-, L120Q-, Y139C-, or
Y139F-Vkorc1 fed with a standard rodent diet. The box extends from the 25th to 75th percentiles and the
line corresponds to the mean. Statistical analyses were performed using a Dunn’s multiple comparisons
test. p < 0.05 was the accepted level of significance. a,b, statistical difference between two groups.
3.2.3. Tissue Calcium Concentration
Calcium concentration was measured in testis, kidneys, lungs, and hearts of rats homozygous for
wild type, Y139C, Y139F, or L120Q fed with a standard rodent diet. Results e presented in Figure 3.
No difference was observed between strains.
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Figure 3. Tissue calcium content in (A) testis, (B) kidney, (C) lung, and (D) heart of rats homozygous 
for WT-, L120Q, Y139C or Y139F-VKORC1 fed with a standard rodent diet. The box extends from the 
25th to 75th percentiles and the line corresponds to the mean. Statistical analyses were performed 
using a Dunn’s multiple comparisons test. 
3.3. Evolution of the Vitamin K Status According to the Vkorc1 Genotype in Rats Receiving a Specific Diet-
K3 for 12 Days 
3.3.1. Vitamin K Concentrations 
Figure 3. Tissue calcium content in (A) testis, (B) kidney, (C) lung, and (D) heart of rats homozygous
for WT-, L120Q, Y139C or Y139F-VKORC1 fed with a standard rodent diet. The box extends from the
25th to 75th percentiles and the line corresponds to the mean. Statistical analyses were performed using
a Dunn’s multiple comparisons test.
3.3. Evolution of the Vitamin K Status According to the Vkorc1 Genotype in Rats Receiving a Specific Diet-K3
for 12 Days
3.3.1. Vitamin K Concentrations
The evolution of MK4 concentrations in different tissues (i.e., testis, kidneys, and lungs) was
determined in rats receiving a vitamin K3 deficient diet for a short period of time from 0 to 12 days.
The esults are presented in Figure 4. This evolution could not be determined in the liver since this
concentration was too low even before the beginning of the deficiency.
Nutrients 2019, 11, 2076 9 of 16
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prothrombin time at day 0, 4, 8, and 12 after the beginning of the vitamin K3 deficiency. Results are 
Figure 4. Vitamins K concentrations evolution in (A) testis, (B) kidney, and (C) lung of rats homozygous
for WT-, L120Q-, Y139C-, r Y139F-Vkorc1 receivi g a specific diet -K3 for 12 days. Results are expressed
as the mean of the percentage of four animals compared to wild type r ts at day 0 ± standard deviation.
Half-lives of MK4 in the different tissues of the different rat strains were calculated using a
non-linear regression model using equation C = (C0)-kel*t. Results are presented in Table 3. Half-life
of MK4 was four-fold long r in testis of the wild type when compared to mutated rats. In kidney,
half-lives were similar for all str ins. In lung, half-life of MK4 was lower in wild type rats when
compared to rats homozygous for L120Q or Y139F.
Table 3. Kinetic parameters of VKOR activity and the ratio between VKORC1 and VKORC1L1 proteins
in different rat tissues according to the Vkorc1 genotype. Results are the mean of four independent
determinations with its 95% confidence interval.
Half-Life of MK4 WT (in Days) L120Q (in Days) Y139F (in Days) Y139C (in Days)
In testis 12.09 a,b,c [10.03–13.82] 3.10 a [2.22–5.11] 3.31 b [2.07–8.21] 2.50 c [1.69–4.74]
In kidney 2.43 [1.78–3.84] 3.85 [2.79–6.27] 1.71 [1.31–2.47] 1.68 [1.34–2.28]
In lung 1.31 a,b [0.91–2.39] 6.60 a [4.41–13.20] 4.08 b [3.37–5.18] 2.37 [1.37–8.93]
p < 0.05 was the accepted level of significance. a, b, and c: statistical difference between two groups.
3.3.2. Prothrombin Time
Consequences of the vitamin K3 deficiency were assessed by the determination of the prothrombin
time at day 0, 4, 8, and 12 after the beginning of the vitamin K3 deficiency. Results are presented in
Figure 5. Prothrombin time was not modified in rats homozygous for the wild type, Y139C, or Y139F
fed with a standard rodent diet. Prothrombin time increased in rats homozygous for L120Q from the
eighth day after the beginning of the vitamin K3 deficiency.
Nutrients 2019, 11, 2076 10 of 16
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4. Discussion 
Anticoagulant-resistant rats due to Vkorc1 gene mutations are good models for mimicking the 
consequences of human VKORC1 mutations. In humans, mutations of the VKORC1 promoter would 
decrease VKORC1 expression and some VKORC1 coding mutations would affect its VKOR activity 
[30]. The consequences of these mutations may, therefore, be different, in terms of activity and/or the 
consequences on vitamin K status. Using the rat as a model, we have considered these possible 
differences depending on the nature of the mutation. For this, we used four different rat strains, the 
OFA-Sprague Dawley rats, and three strains of introgressed rats homozygous for mutations L120Q, 
Y139F, or Y139C, with the amino acid 139 being located near the catalytic site, and the amino acid 120 
Figure 5. Prothrombin time evolution of rats homozygous for WT-, L120Q-, Y139C-, or Y139F-Vkorc1
receiving a specific diet -K3 for 12 days. Results are the mean of 3 or 5 animals, with each point
representing each individual.
3.3.3. Plasma ucOC Concentration
Consequences of the vitamin K3 deficiency were also assessed by determining the plasma ucOC
concentration at day 0, 4, 8, and 12 after the beginning of the vitamin K3 deficiency. Results are
presented in Figure 6. The ucOC concentration remained unchanged during the 12 days of vitamin
K3 deficiency in wild type rats, while, in the other strains, ucOC concentration increased rapidly.
ucOC concentration reached its maximum 4 days after the beginning of the vitamin K3 deficiency
and increased two-fold in rats homozygous for Y139F and Y139C and four-fold in rats homozygous
for L120Q.
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Figure 6. ucOC concentrations evolution in plasma rats homozygous for WT-, L120Q-, Y139C-, or
Y139F-Vkorc1 receiving a specific diet -K3 for 12 days. Results are expressed as the mean of the
percentage of 4 animals compared to wild type rats at day 0 ± standard deviation.
4. Discussion
Anticoagulant-resistant rats due to Vkorc1 gene mutations are good models for mimicking the
consequences of human VKORC1 mutations. In humans, mutations of the VKORC1 promoter would
decrease VKORC1 expression and some VKORC1 coding mutations would affect its VKOR activity [30].
The consequences of these mutations may, therefore, be different, in terms of activity and/or the
consequences on vitamin K status. Using the rat as a model, we have considered these possible
differences depending on the nature of the mutation. For this, we used four different rat strains, the
OFA-Sprague Dawley rats, and three strains of introgressed rats homozygous for mutations L120Q,
Y139F, or Y139C, with the amino acid 139 being located near the catalytic site, and the amino acid 120
being further away from the latter [31]. These strains were derived from the OFA-Sprague Dawley rat
in which the mutated Vkorc1 gene was introduced with less than 0.0001% of the initial genome of the
wild brown rat. We can, thus, legitimately affect the phenotypic modifications to the Vkorc1 mutation.
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We first assessed the impact of the mutation on the ability of each tissue to recycle vitamin K.
For this, we measured VKOR activity from liver, kidney, lung, and testicular microsomes. VKORC1 is
localized in the membrane of the endoplasmic reticulum [2]. The liver is responsible for the activation
of factors II, VII, IX, and X {2]. The kidney, lung, and testis contain high amounts of vitamin K [32] and
calcify strongly in the absence of vitamin K [23]. Regardless of the tissue, microsomal VKOR activity is
always greatly decreased when VKORC1 is mutated, regardless of the position (i.e., amino acid 120 or
amino acid 139) and nature (whether amino acid 139 is replaced by phenylalalanine or cysteine) of the
mutation. Affinity for vitamin K does not seem to be modified (Km unchanged), but velocity of VKOR
activity is systematically greatly reduced (by a factor of 3 to 6 depending on the tissue and the mutation).
This loss of velocity may be due to a malfunction of VKORC1 due to mutations and/or a decrease
in the VKORC1 expression level because of instability of the mutated proteins. The malfunction is
certain. The characterization of the corresponding recombinant proteins has demonstrated this loss
of velocity [33]. On the other hand, this study shows that the VKORC1 expression level remains
unchanged despite the presence of mutations L120Q, Y139F, or Y139C regardless of the tissue, except
in the liver of the Y139F strain where VKORC1 is slightly expressed. Expression of VKORC1L1,
which is another enzyme that is able to catalyze VKOR activity [34] and, thus, compensate for loss of
VKORC1 activity, also remains unchanged except in lungs where its expression is slightly increased to
compensate for the loss of activity of VKORC1 in the lung.
The presence of these mutations in rats that can be considered laboratory rats allowed us to
appreciate the consequences of a decrease in VKOR activity on the “vitamin K” status (Table 4).
This status was evaluated by determining tissue vitamin K concentrations, measurement of plasma
ucOC concentration, and determination of tissue calcium levels. Among the K vitamins, only MK4 was
measured because the rats used received, from the age of 3 weeks up to 8 weeks, a diet supplemented
with menadione as their sole source of vitamin K (the amounts of vitamin K1 in the standard feed
being limited and provided by the cereals incorporated). The latter received virtually no vitamin K1
and, since there is no endogenous synthesis of vitamin K1, vitamin K1 was almost undetectable in
rat tissues. Osteocalcin is a vitamin K-dependent protein produced mostly by osteoblasts [35]. In the
absence of vitamin K, the concentration of ucOC increases rapidly in plasma [36] and is, therefore,
considered a good marker of overall vitamin K status. Tissue calcium concentrations have also been
shown to be negatively correlated with the vitamin K status. In the absence of vitamin K, MGP, which
is another vitamin K-dependent protein, cannot be activated and, therefore, cannot inhibit tissue
calcification [23,37,38].
Surprisingly, while all rats have always received the same standard diet supplemented with
menadione, the vitamin K status of rats homozygous for Y139C and Y139F mutations is strongly altered
with a sharp decrease (by a factor of two to four) in MK4 concentrations in all tissues considered in this
study and a significant increase in plasma ucOC concentration (by a factor of almost 7). The “vitamin
K” status of rats homozygous for the L120Q mutation can be considered an intermediate between the
wild type rat and the rats homozygous for the Y139C or Y139F mutations (Table 4). It is surprising
to observe such a difference in vitamin K status in rats receiving the same diet supplemented with
menadione, even if they have Vkorc1 mutations. This decrease is even more surprising in the liver,
which is the first organ to capture vitamin K from food, where the intake is the same for all strains of
rats. Decreasing the recycling efficiency of vitamin K should eventually lead to a decrease in MK4
concentration, but an increase in MK4OX concentration. This is not observed. These results suggest
a loss of vitamin K induced by the mutation. The metabolism of vitamin K is still largely unknown.
Metabolism of vitamin K byω-hydroxylation [39,40] with involvement of cytochromes 4F2 and 4F11 in
humans has been described. The substrates of cytochromes 4F2 and 4F11 have not been characterized.
In rats, cytochromes metabolizing vitamin K have not been identified. Metabolism of vitamin K in
its epoxide form by cytochromes might be more efficient than in its quinone form. Since recycling of
vitamin K epoxide is less efficient in mutated rats, the elimination of vitamin K could be, thus, increased
via greater cytochrome P450 dependent metabolism of vitamin K epoxide. Nevertheless, the difference
Nutrients 2019, 11, 2076 12 of 16
in status observed between rats homozygous for the L120Q mutation and rats homozygous for the
Y139F and Y139C mutations is surprising, whereas the recycling efficiency of the different tissues is
similar, or even lower, in rats homozygous for the L120Q mutation (the efficiency that corresponds
to Vmax/Km is systematically the lowest). The “vitamin K” status of rats homozygous for the Y139F
or Y139C mutations could be aggravated by a modification of the catalysis mediated by VKORC1
due to the mutation. It has been shown that the replacement of tyrosine 139 by cysteine, and, to a
lesser extent by phenylalanine, allowed VKORC1 to catalyze a 3-hydroxylation activity, in addition
to its activity of reduction [33,41]. The production of 3-hydroxyvitamin K constitutes an additional
pathway of elimination of vitamin K and, thus, precludes the recycling of the vitamin by increasing the
vitamin K requirements in these rats. Wild type VKORC1 and VKORC1 mutated at position 120 do not
produce this 3-hydroxyvitamin K [33].
Table 4. Summary of the results obtained for each strain compared to the WT strain;
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but velocity of VKOR activity is systematically greatly reduced (by a factor of 3 to 6 depending on 
the tissue and the mutation). This loss of velocity may be due to a malfunction of VKORC1 due to 
mutations and/or a decrease in the VKORC1 expression level because of instability of the mutated 
proteins. The malfunction is certain. The characterization of the corresponding recombinant proteins 
has demonstrated this loss of velocity [33]. On the oth r hand, thi  study sh ws that the VKORC1 
expression level remains unchanged des ite the presence of mutations L120Q, Y139F, or Y139C 
regardless of the tissue, except in the liver of the Y139F strain where VKORC1 is lightly expressed. 
Expression of VKORC1L1, which is another enzyme that is abl  to catalyze VKOR activity [34] and, 
thus, compensate for loss of VKORC1 activity, also remains unch ng  ex pt in lungs where its 
expr ssion is slightly increased to compensate for the loss of activity of VKORC1 in the lung. 
The presence of these mutations in rats that can be considered laborat ry rats allowed us to 
appreciate the consequences of a decrease in VKOR activity on the “vitamin K” status (Table 4). This 
status was evaluated by determining tissu  vit min K concentrati ns, measurement of plasma ucOC 
concentration, and determination of tissue calcium levels. Among the K vitamins, only MK4 was 
measured because the rats used received, from the age of 3 weeks up to 8 weeks, a diet supplemented 
with menadione as their sole source of vitamin K (the amounts of vitamin K1 in the standard feed 
being limited and provided by the cereals incorporated). The latter received virtually no vitamin K1 
and, since there is no endogenous synthesis of vitamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitamin K-dependent protein produced mostly by osteoblasts [35]. In the 
absence of vitamin K, the concentration of ucOC increases rapidly in plasma [36] and is, therefore, 
considered a good marker of overall vitamin K status. Tissue calcium concentrations have also been 
shown to be negatively correlated with the vitamin K status. In the absence of vitamin K, MGP, which 
is another vitamin K-dependent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the results obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away from the latter [31]. Th se strains w re derived from the OFA-Spragu  Dawley 
rat n wh ch the u ated Vkorc1 g n  was introduced with less than . 001% of the nitial genome of 
the wild brown rat. We an, thus, legitimately affect the phenotypic mo ifications to the Vkorc1 
mu atio . 
We first as essed the impact of the mu ation on the ability of each tissue to re ycle vitamin K. 
For this, we measured VKOR act vity from liver, kidney, lung, and testicular micr somes. VKORC1 
is localized in the membrane of th  endoplasmic retic lum [2]. The liver is responsible for the 
activation of factors II, VII, IX, and X {2]. The kidney, lung, and te tis contain high amounts of vitamin 
K [32] and calcify strongly in the absence of vitamin K [23]. Regardless of the tissue, micr somal 
VKOR act vity is always greatly decreased when VKORC1 is mu ated, regardless of the position (i.e., 
amino acid 120 or amino acid 139) and nature (whether amino acid 139 is replaced by phenyl l la ine 
or cysteine) of the mu ation. Aff nity for vitamin K does not seem to be modified (Km unchanged), 
but velocity of VKOR act vity is ystematically greatly reduced (by a factor of 3 to 6 depending on 
the tissue and the mu ation). This loss of velocity may be due to a malfunction of VKORC1 due to 
mu ations and/or a decrease in the VKORC1 expression l vel because of instability of the mu ated 
proteins. The malfunction is certain. The ch racterization of the corresponding recombi ant proteins 
has demonstrated this loss of velocity [33]. On the other hand, this st dy shows that the VKORC1 
expression l vel remains unchange  despite th  pr se c  of mu ations L120Q, Y139F, or Y139C 
regardless of the tissu , except in the liver of the Y139F strain wh r  VKORC1 is slightly expressed. 
Expression of VKORC1L1, which is another enzyme that is abl  to c talyz  VKOR act vity [34] and, 
thus, compensate for loss of VKORC1 act vity, also remains unchanged except in lungs wh re its 
expression is slightly in reased to compensate for the loss of act vity of VKORC1 in the lung. 
The pr sence of th se mu ation  in r ts that can be consid red laboratory rats allowed us to 
appreci t  the consequences of a decrease in VKOR act vity on the “vitamin K” s atus (Table 4). This 
s atus was evaluated by d term ing tissue vitamin K concentrations, measurement of plasma ucOC 
concentration, an  d termination of tissue calcium l vels. Among t  K vitamins, only MK4 was 
measured because the rats used r ceived, from the age of 3 weeks up to 8 weeks, a diet supplemented 
with menadione as their sole source of vitamin K (the amounts of vitamin K1 in the standard feed 
being limited and provi ed by the c reals incorporated). The latter r ceived virtually no vitamin K1 
and, since th re is no endogenous synthesis of vitamin K1, vitamin K1 was almost und tectable in rat 
tissues. Osteocalcin is a vitamin K-dependent protein produced mostly by osteoblasts [35]. In the 
absence of vitamin K, the concentration of ucOC increa es rapidly in plasma [36] and is, th refore, 
consid red a good marker of overall vitamin K s atus. Tissue calcium concentrations have also been 
shown to be negatively correlated with the vitamin K s atus. In the absence of vitamin K, MGP, which 
is another vitamin K-dependent protein, cannot be activated and, th refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Table 4. Su mary of th  results obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In te tis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In te tis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away from th l tter [31]. Th se strains w re derived from the OFA-Sprague Dawley 
r  n which the mutated Vkorc1 g ne was intr duc d with less tha  0.0001% of the initial genome of 
the wild brown rat. W  can, thus, legitimatel  affect the phe typic modifi ations to the Vkorc1 
mutation. 
W  first assess d the impact of the mutati n on the ability of each t ssue to recycle vitamin K. 
For this, we measured VKOR activity from liver, kidney, lung, and testicular microsomes. VKORC1 
is localized in the membrane of the endoplasmic reticulum [2]. The liver is r sponsible for the 
activation of factors II, VII, IX, and X {2]. The kidney, lu g, and testis contain high amounts of vitamin 
K [32] and calcify strongly n he absence of vit min K [23]. Regardless of the tissue, microsomal 
VKOR activit  is always greatly decreased when VKORC1 i  mu a ed, regardless of the position (i.e., 
a i  aci  20 or amino acid 139) and nature (whether amino acid 139 is replaced by phenylalalanine 
or cysteine) o  the muta ion. Affinity for vita in K does not s em to be modified (Km unchanged), 
but velocity of VKOR ctivit  is s st matically gre tly educed (by a factor of 3 to 6 depending on 
the tissue and the mutati n). This loss of velocity y be due to a malfunction of VKORC1 due to 
mutation  and/or a decrease in the VKORC1 expr si  leve  because of ins bility of the mutated 
prote n . Th  malfun tion is ert in. The chara t ization of th  c rresponding recombinant proteins 
as dem nstrated his loss of velocity [33]. On the other hand, t is study shows that the VKORC1 
expression level rem ins unc ang d despite th  presence of mutations L120Q, Y139F, or Y139C 
regardless of the tissue, except in the liv r of the Y139F stra n wh re VKORC1 is slightly express d. 
Expression of V ORC1L1, which is another enzyme that is able to catal ze VKOR activity [34] and, 
thus, compensate for loss of VKORC1 ctivity, al o remai s unchanged xcept in lungs where its 
expression is slightly incr ased to c mpens te for the loss o  act vi y of VKORC1 in the lung. 
The presence of the e mutatio s in rat  that can be c nsidered aboratory rats allowed us to 
appre iate the consequ nces of a de rease in VKOR activity on the “vit min K” tatus (Table 4). This 
status was evalua ed by deter i ing tissue v tamin K concentrations, me s rement of plasma ucOC 
concentration, and det rminat on of tis ue calcium levels. A ong the  vitamins, only MK4 was 
measured b caus  the ats us d received, fr m the age of 3 weeks up to 8 weeks, a iet supplemente  
wi  menadione as their sole source of vitamin K (the amoun s of vi min K1 in the standard feed 
being limited and p ovided by th  cereals inco po at d). The l tter received virtually no vitamin K1 
and, since there i  no endogenous synthesis of vitamin K1, vitamin K1 was almost undetectable in rat 
ti sues. Osteocalcin is a vitamin K-de end nt pro ein pr duc d mo tly by os eoblasts [35]. In the 
absence of vitamin K, the concentr tion of ucOC i cre es rapidly n plasma [36] and is, therefore, 
consid ed a good marker of overall vitamin K status. Tissue calcium concentrations have also been 
shown to be n gatively correlated wi h the vitamin K status. In the absence of vitamin K, MGP, which 
is anoth r vitamin K-depe dent protein, c not b  activated and, t erefore, cannot inhibit tissue 
calcification [23,37,38]. 
Tabl  4. Summary o  th  r sult  obtained fo  eac strain compare  to th  WT strain;  , decrease 
compared to WT strain;  , increa e for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
KOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKO C1L1 CONCENTRATION 
In liver = = = 
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being furthe  aw y from the latter [31]. Th se strains were derive  from the OFA-Sprague Dawley 
rat in which th  mutated Vkorc1 gene was introduced with less than 0.0001% of the initial genome of 
the wild brown rat. We ca , thus, legit m ely affect the phenotypic modifications to the Vkorc1 
mutation. 
We first assess d the i p t of h  mutation on the ability of each tissue to recycle vitamin K. 
For this, we measured VKOR activit  fro  liver, kidney, lung, and testicular microsomes. VKORC1 
is localized in th  me br ne of th  ndopla mic reticulum [2]. The liver is responsible for the 
activation of factors II, VII, IX, and X {2]. The kidney, lung, and testis contain high amounts of vitamin 
K [32] and c lcify trongly in the absence of vita n K [23]. Regardless f the tissue, microsomal 
VKOR activity is alway greatly ecre s d when VKORC1 s mutated, regardless of the position (i.e., 
a ino acid 120 or amino acid 139) and nature (whethe  mino acid 139 is rep ced by phenylalalanine 
or cystei e) of th  mu a ion. Affinity for vitamin K does ot seem to be modified (Km unchanged), 
but velocity of VKOR activit  is systematically greatly reduced (by a factor of 3 to 6 depending on 
the tissue and the mutation). This oss f v l city may be due to a malfunction of VKORC1 due to 
mutations a d/or a decr as  in the VKORC1 xpression level because of instability of the mutated 
pro ei s. Th  m lfu c ion is c tai . The c aracter z tion of the corresponding recombinant proteins 
has demo s ra ed t is loss of v l cit [33]. On the other and, this study shows that the VKORC1 
xpress o  l vel remains u h nged d spite the pre ence of mutations L120Q, Y139F, or Y139C 
regardless of the tissu , exc pt in the liver of the Y139F strain where VKORC1 is slightly expressed. 
Expressio  of VKORC1L1, whi h is a other nzyme that is ble to catalyze VKOR activity [34] and, 
thus, ompen at  for loss of VKORC1 ac ivity, lso r mains u changed exc p  in lungs where its 
ex ession is slightly i reased o comp nsa e for the loss of activity of VKORC1 in the lung. 
Th prese ce of hese mut tions in rats th t can be considered laboratory rats allowed us to 
appr ciate the ons que ces of a decrease i  VKOR ctivity on the “vitamin K” status (Table 4). This 
status w s evaluated by de er ining tissu  vi ami  K con ntrati ns, mea urement of plasma ucOC 
conc ntration, and determin tion of ti sue calcium levels. Among the K vitamins, only MK4 was 
m asured because the rats u ed received, from the age of 3 we ks up to 8 weeks, a diet supplemented 
with e adi n  s their ole sourc  of vitamin K (the ounts of vitamin K1 in the standard feed 
being limited an  provided by the cereals incorp rated). The latter rece ved virtually no vitamin K1 
and, inc  there s no nd ge ous synthesis of vitamin K1, vitami  K1 w s almost undetectable in rat 
tis ues. Osteocalcin is a vita in K-dependent pr tein produc d mostly by osteoblasts [35]. In the 
absence of vitamin K, the once tration of ucOC increases rapidly in plasma [36] and is, therefore, 
considered  good m rk r of overall vi amin K tatus. Ti sue calcium concentrations have also been 
s own to be negatively correlat d with the vitamin K status. In t e absence of vitamin K, MGP, which 
is a other vitamin K-depe dent protein, ca ot be act vated a d, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summ ry of the results obtained for ea h str in compared to the WT strain;  , decrease 
comp red to WT strain;  , incre se fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
In testis
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being furt er away from the latter [31]. Th se strains ere d rive  from the OFA-Spragu  Dawl y 
ra  in hich the mu ted Vkorc1 ge e was introduced with l ss than 0.0001% of t e i i i l gen me f 
the wild brown rat. We ca , thus, legitimately affect the phenotypic modifications to the Vkorc1 
mutation. 
We first ass s  the impact of the utation on th  ability of e h tissue to recycl  vitamin K. 
For this, we measur d VKOR activity from liver, kidney, lu g, and testicula  microso es. VKORC1 
is localized in the membra e of the endoplasmic reticulum [2]. The liver is respo sible for the 
activatio  of fa tors II, VII, IX, a d X {2]. The kidney, lung, a d testis contain high amounts of vita in 
K [32] nd calcify strongly in he abs nc  of vi amin K [23]. Regardless of th  tissu , micr s mal 
VKOR tivity is always greatly decre sed wh n VKORC1 is mutated, regardless of the po ition (i. ., 
amino acid 120 or a ino cid 139) a d nature (whether amino acid 139 is replaced by phenylal l in  
or cysteine) f the m t tion. Affinit  for vitamin K does not se m to be modified (Km unchanged), 
but velocity of VKOR ctivity is y te atically greatl  red c d (by a factor of 3 to 6 depending  
the tissue and the mutation). This loss of velocity may be due to  malfunction of VKORC1 du  to 
mutatio  and/or a decrea e in the VKORC1 expressi  level b au  of i stability of the mutated 
proteins. The m lfunction i  cer ain. T e characteriz ti n of the corre pon ing recombinant proteins 
as demo strated this lo  f v locity [33]. On the oth r h nd, this study hows that the VKORC1 
expression level mains unchang d d pite the pres nce of mutati ns L120Q, Y139F, or Y139C 
r gardl ss f the tissue, xcept in the liver of the Y139F strain where VKORC1 is slightly xpr sse . 
Expressi n of VKORC1L1, which s an ther nz me that is abl  to alyz  VKOR a tivity [34] d, 
thus, comp ate for los  of VKORC1 activity, also r ains unchanged except i  lungs where its 
expression is slightly increased to compensate fo  the los  of activity of VKORC1 in the lung. 
The presence of th s  utations in ats that c n be consid r d l bo atory rat  allowed us to 
appreciate th  con eq ence  of a ecrea  i  VKOR activity n the “vita in K” status (Tabl  4). This 
status w s evaluate  by determi ing tiss  vit mi  K concent ations, easure t of plasma ucOC 
concentration, and d t rmination of tissue calciu  levels. Among th  K itamins, only MK4 as 
measur d becaus  the rat  use  rec iv d, fro  the age of 3 w eks up t  8 weeks, a diet suppl ment  
with menadione as their sole sourc  of vitamin K (the am unts f vit min K1 in th  stand r  feed 
bei g limit d and provi ed by the cereal  inc rpor ted). The latter received virtually no vit mi  K1 
and, since there is o endogenous synth is of vitamin K1, vit min K1 was almost u detectable in rat 
tis ues. Osteocalcin is a vitamin K-depe dent protein produc  mostly by osteoblasts [35]. In the 
abse c  of vit min K, the concentration of ucOC increases rapidly in plasma [36] a d is, ther fo , 
considered a good marke  of overall vitami  K status. Tis e alcium co ntrations hav  als  bee  
show  to be neg tively c rrelated with the vit min K status. In the absenc  f itami  K, MGP, which 
is another vitamin K-dependent protein, cann t be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the re ults bta ed for each strain compared t the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liv r    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liv r    
In testis    
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away from the l tter [31]. Th se strains r  de ived from t e OFA-Spra u  Dawley 
rat in which the mu ated Vkorc1 g ne was introduced with l ss than . 001% of th  itial genome of 
the wild brown rat. We can, thus, legitimately affect the phenotypic modifications to the Vkorc1 
mu ation. 
We first ess  the impact of the u ation on th  ability of ea h tiss e t  re ycl  vit mi  K. 
F r this, we measur d VKOR act vity from liver, kidn y, lung, d t sticula  icr som s. VKORC1 
is localized in the membrane of th  endoplasmi  retic lum [2]. The liver is respo sible for th  
activ tio  of fa tors II, VII, IX, nd X {2]. The kidney, lung, a d te tis co tain igh amounts of vita in 
 [32] nd calcify strongly in the bsence of i amin K [23]. Regardless of the tissu , mic so al 
VKOR t vity is lways greatly decre sed when VKORC1 is mu at d, r gardless of the positio  (i.e., 
amino acid 120 or a ino acid 139) and nature (whether amino cid 139 is replace  by phenylal la ine 
or cysteine) f the mu tion. Aff nity for vitamin K do s not seem to be m dified (Km u changed), 
but velocity of VKOR ct vity i  ystem tically greatl  reduc d (b  a factor of 3 to 6 depending on 
the tissue and the mu ation). T is loss of velocity may be due to  malfunction of VKORC1 du  to 
mu ations and/or a d crea  in the VKORC1 xpre si  l vel bec u e f instability of the mu at d 
proteins. The malfunction is c tain. The ch ract ization of the corr ponding recombi an  proteins 
has demo strated this loss of velocity [33]. On he oth r hand, t is stu y show  that th  VKORC1 
expres ion l v l mains unchange  d spi  the pr ence f mu ations L120Q, Y139F, or Y 39C 
regardless of the tissu , except the liv  of t e Y139F train wh re VKORC1 is slightl  expresse . 
Expressio of VKORC1L1, which is another enzyme th t i  able to c talyz  VKOR act vity [34] and, 
t u , compen ate f r lo s of VKORC1 a t vit , also re ins unchanged xcept i  lungs wh re its 
expression is slightly i creased t  compen ate for the loss of act vity of VKORC1 in the lu g. 
Th  pr se c  of th  mu ations in rats that  be co sid red l borat ry rat  llowed us o 
ppreciate the consequenc s of a d crea e in VKOR act vit  on the “vit min K” s atus (T ble 4). T is 
s atus w s ev luate  by d term ing tiss  vit i K conc ntr tions, measure e t of plasma ucOC 
concentration, an  d te mination of tis e calcium l vels. A ong th  K vit mins, only MK4 was 
measur  becau e the rat  u ed ceived, fro  the ag  of 3 weeks up to 8 weeks, a diet supplem nt  
with enadione as their sol  source of vita in K (th  amounts of vitamin K1 in the stan rd feed 
being limited and provi d by the c real  incorporated). The latter r ceived virtually no vit mi  K1 
and, since th re is o endogen us sy th sis of vitamin K1, vitamin K1 was almost und t cta le in rat 
tis u s. Osteocalcin is a vitamin K-depe dent prot i  produce  mostly by steoblasts [35]. In the 
absenc  of vitamin K, the c ncentration of ucOC increa es r pidly in plasm  [36] and is, th r fore, 
consid r d a good marke  of overall vitamin K s atus. Tis ue c lcium concentrations have lso been 
shown to be negatively corr lated with th  vitamin K s atus. In the absen  f vit min K, MGP, which 
is another vitamin K-dependent protein, cannot be activated and, th refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Table 4. Su mary f th re ults obta d for each strain compared to t e T strain; , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In te tis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver    
In te tis    
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being fur  way from the la ter [31]. Th  strains ere deriv  f om the OFA-Sprague Dawl y 
rat in which the mu a ed Vkorc1 g e as i troduced wit  less an 0.0001% t e ini ial gen me of 
the wild brown rat. We ca , thus, legitimately affect the phenotypic modifications to the Vkorc1 
mutation. 
We first sse sed the impact f the mut tion on t e ability of ea h tissue to recycle vitamin K. 
Fo  this, w  measur d VKOR activit  from liver, kidn y, l g, and testicular micro ome . VKORC1 
is loc lized in the membr e of the endoplasmic reticulum [2]. The li er is resp nsible for the 
activation of f ctor II, VII, IX, a d X {2]. Th  kidney, lu g, a d t ti  co ain h g  amounts of vitamin 
K [32] and calcify tro gly i  the absence of vi amin K [23]. Regar less f th  tissue, microsomal 
VKOR activi y is lw ys gr atly d cre sed when VKORC1 is mutated, regardless of the po ition (i. ., 
amino cid 120 or ami o acid 139) and nature (whethe  ami  aci  139 is rep c  by phenylalalanin  
or cystei e) of the m tation. Affinity for vitamin K do s not s m to b  m difi  (Km unchanged), 
but vel cit  of VKOR ac vity is syste atically gre tly reduced (by a f ctor of 3 t  6 depending  
the tissue a d the mutation). Thi  l ss of v locity may be du  t  a malfunction of VKORC1 d e to 
m tati s a d/or a decrea in th  VKORC1 expre si  level caus  f i stability of the mutated 
pro ei . The m lfunction i  c a n. T e c racte izati  of the corresponding r combinant proteins 
has d onstrat d this lo f v l city [33]. On  her and, this study shows that the VKORC1 
xpressi  level remain  nc a g d spite t  p e ce of mutations L120Q, Y139F, or Y139C 
regardless of he issu , xcept in the live  of the Y139F stra  where VKORC1 i  slightly expr ssed. 
Exp essi n of VKORC1L1, which is an her enzyme hat is able to c talyze VKOR a tivity [34] and, 
t us, c mpensat  for los  of VKORC1 activity, lso r ains u c anged exc p n lungs where its 
expres ion is slightly i cre s d o c mp sa e for the l s  of activity of VKORC1 in the lung. 
T pres nce of th se mut ions in rats t at c n e considered laboratory r s allowed us to 
ppr ciat  the cons quences of a de rea e i  VKOR ctivity o the “vita in K” status (Tabl  4). This 
s atus was valu ted by d er i ing tissue vi mi  K conc ntrati s, asurement of plasma ucOC 
conc nt at on, d d termin tion of ti sue calci m l v ls. A o g the K vitamin , only MK4 was 
m asured b caus  the rats use rec ived, fro the age of 3 weeks up to 8 weeks, a diet supplement d 
with menadi ne as their sole sou c  of vitamin K (the amounts f vit min K1 in th  standar  feed 
being l mit d and pr vided by the cereals incorporated). The l tter rece ed vi tu lly no vit min K1 
and, inc  th re is no ge ous sy the is of v ta in K1, vitamin K1 w s alm t undetectable i  rat 
tis u s. Osteo lci  is a vitamin K-d pendent pr tein produced mostly by ost obl sts [35]. In the 
absence f vitamin K, the once t tion of u OC increases rapidly in pl sma [36] and is, ther fo , 
consider d a good m rk r of ov rall vitamin K st tus. Tissue c lcium concentratio s hav  als  been 
shown t  be egatively c rrel t d with the vitamin K st tus. In he absence of itamin K, MGP, which 
is another vitamin K-depe den protein, can ot be activat d d, herefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. S m ry of th results bt i ed for ach s rain comp red t  the WT strain;  , decrease 
compared to WT st ain;  , increase fo  WT s rain; =, similar with WT strain. 
 L120Q 139F Y139C 
VKOR ACTIVITY 
In liver    
I  testis    
In kidney    
In lung   = 
VKO C1 C CENTRATION 
In liver =  = 
 testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 C CENTRATION 
In liver = = = 
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bei g fu t er away from the l tter [31]. Th se st ains w re de ived from t  OFA-Sprague Dawley 
rat in whic  the mu a ed Vkorc1 g n  was i trodu d with less than . 001% of the ni ial g nome of 
the wild brown rat. We can, thus, l gitimately affect the pheno ypic modifications to the Vkorc1 
mu ation. 
We firs as essed the impact of the u tion o  the ability of ach tiss e to re ycle vit min K. 
For this, w  measur VKOR act vit  from liver, k dn y, l ng, nd testicular icr som s. VKORC1 
is localiz d in the membr ne of th  endoplasmic retic lum [2]. Th li er is respon ible for the 
activatio  of factor  II, VII, IX, and X {2]. Th  kidney, lung, and t tis co ta n high amounts of vitamin 
K [32] d calcify trongly i  the bsence of vitamin K [23]. Regardless f th  tissue, mic somal 
VKOR ct vity is lw ys greatly d crea ed wh n VKORC1 i  mu at d, regardless of t  position (i. ., 
amin  acid 120 or amino acid 139) nd ature (wheth  amino cid 139 is rep c  by phe yl l la ine 
or cystei e) of the mu tion. Aff nity f r vitamin K d es not see  to b  modified (Km unchanged), 
but vel cit of VKOR act vity is ystem ticall gre tly re ced (b   factor f 3 to 6 depen ing n 
the tis ue a  the mu ation). Thi  l ss of v locity may b  due t  a malfu ction of VKORC1 du  to 
mu ations a d/or a d c eas  i  the VKORC1 xpr ss n l vel because f instability of the mu ated 
pro i . The malfunction is c tain. The c rac erization of the corr sponding r combi ant proteins 
has demonstrated this loss of v l city [33]. On the ther an , t is study shows that t VKOR 1 
xp essio  l v l mains unchang  d spit  the pr e ce f mu ati ns L 20Q, Y139F, or Y 39C 
regardl ss f tissu , xcept in the liver of t e Y139F str in w re VKORC1 is slightly expressed. 
Expressi n of VKORC1L1, which is an th r nzyme that is able o c talyze VKOR act vity [34] and, 
thu , c mpensate for lo s f VKORC1 act vity, lso remains u c anged exc p  in lungs wh re its 
expr s ion i slightly i creased o compen a e for the l ss of act vity of VKORC1 in the lung. 
Th pr s c  of th se mutations in rats tha  c n be consid red laborat ry rats allowed us o 
appr ci t the con que c  of  de reas  i  VKOR a t vity o  the “vita in K” s atus (Table 4). This 
s atus w s evaluated by d er ing tissue vi ami  conc ntr ti ns, easure ent f plasma ucOC 
conc ntr ti , an  d te mination of ti sue calcium l v ls. A ong th   vit mins, only MK4 was 
m sur d becaus  t  rats used rec ived, from the ag  of 3 weeks up to 8 weeks, a di t supplemented 
with mena i  as their sol source of vi amin K (th amo nts of vitamin K1 in the standard feed 
being limited and provi ed by the c real  inco por t ). The latt r r ce ved vi ally no vit min K1 
and, inc  th re is no gen us sy thesis of vitami  K1, vitami  K1 w s almost und tecta le in rat 
ti ues. Osteoc lci  is a vitami  K-dependent pr tein produced mostly by ost oblast  [35]. In the 
ab en e f vitamin K, the onc tration of ucOC incr a es rapidly in pl sma [36] and is, th refore, 
c nsid r d a good m rke  of over ll vitamin K atus. Ti sue c lcium concentr tio s have also been 
shown to be egatively correlat d with th  vit min K s atus. I  the abs n e of vit min K, MGP, which 
is another vitamin K-depe dent protein, can ot be activated a d, th refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Table 4. Su m ry of th re ults obt i ed for each strain compared to th  str i ;  , decrease 
compa d to WT strain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In te tis    
 kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In te tis = = = 
I  kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
Nutrients 2019, 11, x FOR PEER REVIEW 11 of 16 
 
being furthe  a ay fr m th l tt r [3 ]. T s  strains r  derived from the OFA-Spragu  Dawley 
r  in which th  mu a ed Vkorc1 g ne was introduced with less tha  0.0001% of the i itial genome of 
the wild brown rat. We ca , thus, legit m el  affect the phe typic modifi ations to the Vkorc1 
mutation. 
W  first assess  the impact of h  mut ti n on the ability of each t ssue to recycl  vitamin K. 
For this, w  easur d VKOR activity from liver, kidney, lung, and testicula  microsomes. VKORC1 
is localize  in th  me brane of th  ndopla mic reticulu  [2]. The li er is r spo sible for the 
activati of fa tor II, VII, IX, an  X {2]. The kidney, lu g, and te tis contain high amounts of vita in 
K [32] nd c lcify strongly  h  absenc  of vit n K [23]. Regardless f th  tissu , micr somal 
VKOR tivit  is alw y greatly cr s  when VKORC1  mu a ed, regardless of the position (i.e., 
a i  aci  20 r a i  acid 139) and natur (whether mino acid 139 is replac by phenylal lanine 
or cysteine)  th  m ion. Affinity f r vita in K does ot s em to b  modified (Km unchanged), 
but l it  of VKOR ctivit  is st matically gre tl  e c d (by a factor of 3 to 6 depending on 
the tissue a d the mutati n). This ss f vel city y be du to  malfunction of VKORC1 due to 
mutation  and/or a decr a e in the VKORC1 expre si  l ve  becau e of ins bility of the mutated 
prote n . T  m lfu io  is i . T e chara z tion of th  c rre ponding recombinan  proteins 
as dem stra ed is loss of vel cit [33]. On the th r hand, t is study shows that the VKORC1 
xp ss on l v l rema ns unc nged d spite th  presence f mutations L120Q, Y139F, or Y139C 
regardless of th  tissue, exc pt i  th  liver of the Y139F stra n where VKORC1 is slightly expresse . 
Expressi  of VKORC1L1, whi h is another zy e that is ble to catal z VKOR activity [34] and, 
thus, compe ate for loss of VKORC1 c ivity, also remains u c anged xcept i  lungs where its 
ex es ion is slightly i r as  to c mpens te for the l ss of act vi y of VKORC1 in the lung. 
Th  prese ce of the  mutatio s in rat  h t c n be consid red boratory rat  allowed us to 
appr iat  t e onsequ ces f a de rea e in VKOR ctivity on the “vit in K” tatus (Table 4). This 
status w s evalua e  by deter ining tiss  v tami  K con entrations, me s re e t of plasma ucOC 
conc ntration, and d t rminat n of tis ue calci m l v ls. A ong the  vitamins, only MK4 was 
m asur d b caus the at  u d rec ived, fro  t e age of 3 w ks up to 8 weeks, a iet supplement  
wi  e adi n  s t ir ole sourc  of vitamin K (the oun s of vi min K1 in the stand rd feed 
b ing limi ed an  p ovi ed by th  cereal  inco p at d). The l ter received vi tually no vitami  K1 
and, i ce there   oge us synth i of vitamin K1, vitamin K1 was almost undetectable in rat 
ti ues. steo alcin is  vita in K-de end nt pro ein pr duc  mostly by os oblasts [35]. In the 
absenc  f vitamin K, the once tr tion of ucOC i cre es rapidly n pl sma [36] and is, therefore, 
consid r d  good mark  of overall vi amin K tatus. Ti ue alcium concentrations have also been 
s own to be gati ely correlat d wi h th  vitami  K statu . In t e absenc f vitamin K, MGP, which 
is a oth r vitamin K-depe dent protein, ca not b  act vated and, t erefore, cannot inhibit tissue 
calcification [23,37,38]. 
Tabl  4. Summary o  th r ul  obt ed fo  ea str in compare  to th  WT strain;  , decrease 
comp red to WT strain;  , incre e for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver    
In testis    
In kid ey    
In lung = = = 
VKO C1L1 CONCENTRATION 
In liver = = = 
In kidney
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being furt er a ay f om t e latter [31]. Th se strains ere derived from the OFA-Spragu  Dawl y 
ra  in hich the mut t d Vkorc1 gene was introduced with l ss han 0.0001% of the i iti l genome f 
the wild brown rat. We can, thus, legitimately affect the phenotypic modifications to the Vkorc1 
mutation. 
We first ass s e  t e impact of the utation on the ability of e h tissue to recycl  vitamin K. 
For this, we measur d KOR activity fro  liver, kidney, lung, and testicula  microso es. VKORC1 
is localized in the membrane of the endoplasmic reticulum [2]. The liver is respo sible for the 
activatio  of fa tors II, VII, IX, a d X {2]. The kidney, lung, and testis contai  high amounts of vita in 
K [32] and calcify strongly in he abs nc  of vitamin K [23]. R gardless of th  tissu , micr s mal 
VKOR tivity is alw ys greatly decreased wh n V ORC1 is utated, reg rdless of the position (i.e., 
amino acid 120 or a ino acid 139) a d nat re (whether amino acid 139 is replaced by phenylal l ine 
or cysteine) f the utation. Affinit  for vitamin K doe  not seem to be mo ifi  (Km u changed), 
but velocity of VKOR ctivity is y te atic lly greatl  red c d (by a ctor of 3 to 6 depending on 
the tissue and the ut tion). This l ss of velocity may be due to  malfuncti n of VKORC1 due to 
mutatio  and/or a decrease in th  VKORC1 ex ressio  l vel b au e of instabil ty f the mut ted 
proteins. The m lfunction i  cert in. T e characteriz ti n f the corr p ing reco binant protein  
has demo strated thi lo  of velocity [33]. O  the other h nd, this study hows that the VKORC1 
expression level rem ins unchanged d spite the presenc  f mutations L120Q, Y139F, or Y139C 
regardless f the tissue, xce t in the liver of the Y139F strain where VKORC1 is slightly xpresse . 
Expressi n of VKORC1L1, which is another enzyme that is ble to atalyz  VKOR activity [34] d, 
thus, compen ate for lo s f VKORC1 activity, also r ain  unchang d exc pt i  lungs where its 
expression is slightly increased to compensate fo  the lo s of ctivity of VKORC1 in the lung. 
The pr sence of thes  mutati s in ats that c n be consid r d l bo atory ra  allowed us to 
appreciate th  con equences of  decrea e in VKOR activity on the “vita in K” st tus (Table 4). This 
status w s evaluate  by determining tiss  vit mi  K c ncent ations, measure t f plasma ucOC 
concentration, and d t r ination of tissue calcium l els. Am ng th  K itamins, only MK4 s 
measur d becaus  the rat  used receiv d, f o  the age of 3 weeks up t  8 weeks, a diet suppl ent  
with menadione as th ir sole sourc  of itamin K (t  am u ts of vitamin K1 in the standard feed 
bei g limit d and provi ed by t e cereals inc rpor ted). T  latter received irtu lly no vitami  K1 
and, since there is o endogenous synth sis of vitamin 1, vitami  K1 was al st u etectable in rat 
tis ues. Osteocalcin i  a vitamin K-depe d nt protein pr duc  mostly by osteoblasts [35]. In the 
abse c  of vit min K, the concentration of ucOC increases rapidly in plasma [36] a d is, therefor , 
considered a good marke  of ov rall itami  K st tus. Tis e alciu  co centrations h ve also bee  
show  to be neg tively correlated with the vit mi  K status. I  the absenc  f vitami  K, MGP, whi h 
is another vitamin K-depende t protein, cann t be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the re ults obta ed for each  comp r d to the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liv r    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liv r =  = 
In testis = = = 
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
Nutrie ts 2019, 11, x FOR PEE REVIEW 11 of 16
 
being further aw y from t e latter [31]. Th se strains r  derived from th  OFA-Spra u  Dawl y 
rat in which the mu ate  Vkorc1 g ne was introduced wi h l ss han . 001% of th  itial genome of 
the wild brown rat. We can, thus, legitimately affect the phenotypic modifications to the Vkorc1 
mu ation. 
We first esse  t e impact of the u ation on the ability of ea h tissue t  re ycle vitami  K. 
F r this, we measur d KOR act vity fro  liver, kidney, lung, d t stic la  micr somes. VKORC1 
is localized in the membrane of th  endoplas ic retic lum [2]. The liver is resp sible for t  
activatio  of fa tors II, VII, IX, and X {2]. The kidney, lung, a d te tis contain igh amount  of vita in 
 [32] and calcify strongly in he absence of i amin K [23]. Regardless of the tissu , micr so al 
VKOR t vity is always greatly decre sed when V ORC1 is mu ated, r g rdless of the positio  (i.e., 
amino acid 120 or a ino acid 139) and n ture (whether a ino acid 139 is replace  by phenylal la ine 
or cysteine) f the u ation. Aff nity for vitamin K do s not seem to be m difi  (K  u changed), 
but velocity of VKOR ct vity i  ystematically greatl  reduc d (by a f ctor of 3 to 6 depending n 
the tissue and the ti ). T is loss of v locity may be due to a malfu ction of VKORC1 du  to 
mu ations and/or a decrea  in the VKORC1 x ressi  l vel b ca se of nstability of t e mu ated 
p oteins. The malfunction is cer in. T e ch ract iza on of the corr pon ing r combi ant pr tein  
has emo strated this lo s f velocity [33]. O  t e oth r hand, this stu y sh ws th t th  VKORC1 
expres i n l vel r m in  unchange  despite the pr enc  of mu ation  L120Q, Y139F, or Y139C 
regardless of th  tissu , except in the liv  of the Y139F train wh re VKORC1 is slightl  expresse . 
Expression of VKORC1L1, which is another enzyme th t i  able to c talyze VKOR act vity [34] and, 
thu , compen at  for lo s f VKORC1 act vity, also re ai s unchang d except i  lungs wh re its 
expression is slightly increased t  c mpen ate for the lo s of ct vity of VKORC1 in the lu g. 
Th  pr se c  of th se u ati s in rats that  be consid red laboratory rat  llowed us to 
ppreciate the con equences of  d crea e in VKOR act vit  on the “vit min K” s atu  (Table 4). This 
s atus w s ev luate  by d term ing tissu  vitamin K conc ntrations, mea ure e t of plas a ucOC 
concentration, an  d termination of tis e calcium l els. A ong the K vit mins, only MK4 w s 
measur  becau e t e rat  u ed ceived, f m the age of 3 weeks up to 8 weeks, a diet supple nt  
with enadione as their sole source of ita in K (the mou ts of vitamin K1 in the stan ard feed 
being limited and provi d by the c real  incorporated). The latter r ceived irtually no vita i  K1 
and, since th re is o endogenous synth sis of vitamin K1, vitamin K1 was almost und t ctable in rat 
tis ues. Osteocalcin is a vitamin K-depe d nt prot i  prod ce  ostly by steoblasts [35]. In the 
absenc  of vitamin K, the c ncentration of ucOC increa es r pidly in plasm  [36] and is, th r fore, 
consid r d a good marke  of ov rall itamin K s atus. Tis ue calcium concentrations hav  lso been 
shown to be negatively co r lated with the vitami K s atus. In the absenc  f vit min K, MGP, whi h 
is another vitamin K-depe dent protein, cannot be activated and, th refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Table 4. Su mary f th re ults obta d for each strain comp r d to t e T stra n; , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In te tis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver =  = 
In te tis = = = 
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
Nutrien s 2019, 11, x FOR PEER REVIEW 11 of 16 
 
being fur  way fro  the la ter [31]. Th  strains ere d rive  f om the OFA-Spragu  Dawley 
ra  in hich the mu ed Vkorc1 g e as introduced with l ss an 0.0001% f t e i i ial gen me f 
the wild brown rat. We ca , thus, legiti ately affect the phenotypic modifications to the Vkorc1 
mutation. 
We first ss s e  the impact f the ut tion on t e ability of ea h tissue to recycl  vitamin K. 
Fo  this, w  measur d VKOR activit  from liver, kidn y, lu g, and testicula  icrosomes. VKORC1 
is localized in the membr ne of the endoplasmic reticulum [2]. The li er is respo sible for the 
activatio of f tor II, VII, IX, a d X {2]. The kidney, lung, a d t ti  co ain h gh amounts of vita in 
K [32] nd calcify tro gly i  he abs nc  of vi amin K [23]. Regardless f th  tissu , micr s mal 
VKOR a tivi y is lw ys gr atly d cre sed wh n V ORC1 is mutated, regardless of the po ition (i.e., 
amino acid 120 or a i o aci  139) a d nature (whethe  amino aci  139 is rep c  by phenylal l in  
or cystei e) f the m t tion. Affinit  for vitamin K do s not se m to b  modifi  (Km unchanged), 
but vel cit  of VKOR c vity is syste atical y gre tl  reduced (by a factor of 3 t  6 dependi   
the tissue a d the mutation). Thi  lo s of v locity may be due t   malfunction of VKORC1 due to 
m tati s a d/or a decr as in th  VKORC1 expres i  level au e of i stability f the mutated 
pro ei s. The m lfunctio  i  c a n. T e c racte izati  of th  corre pon ing r co bi ant proteins 
h s demonst  this lo f v l city [33]. On e her a d, this study hows that the VKORC1 
xpressio  level rema n  u changed d spite t  pre ence of mutations L120Q, Y139F, or Y139C 
regardless of he issu , xcept in the live  of the Y139F strain where VKORC1 i  slightly expresse . 
Exp essi n of VKORC1L1, which is an her nz me hat is able to talyz  VKOR a tivity [34] and, 
t us, c mpen ate for los  of VKORC1 activity, lso r ains u c anged exc p lungs here its 
expres ion is slightly i cre s d o comp nsa e for the l s  of activity of VKORC1 in the lung. 
T presence of th s mut ions in rats t at c n e consid r d l boratory rat  allowed us to 
ppr ciat  th cons que ces of a de rea e i  VKOR ctivity on the “vita in ” status (Tabl  4). This 
s atus w s valuate  by d er i ing tiss  vi mi  K conc ntrations, easure e t of plasma ucOC 
conc nt at on, a d d ter in tion of ti sue calci m lev ls. A o g the K vitamin , only MK4 was 
m asur d because the rat  use rec iv d, fro the age of 3 weeks up to 8 weeks, a diet supplement  
with menadi ne as their sole sou c  of vita in  (the amounts f vit min K1 in th  standar  feed 
bei g l mit d and provided by the cereals inc rpor ted). The latter rece ed vi tu lly no vit min K1 
and, inc there is no n ge ous sy th is of v ta in K1, vitamin K1 w s al ost undetectable in rat 
tis ues. Osteo alcin is a vitamin K-d pe dent pr tein produce  mostly by osteoblasts [35]. In the 
abse c  f vit min K, the once tration of u OC increases rapidly in pl sma [36] and is, ther fo , 
consider d a good m rke of overall vitamin K st tus. Tis e calcium co c ntratio s hav  also been 
show  t  be eg tively c rrel ted with the vit min K status. In he absenc  f itami  K, MGP, which 
is another vitamin K-depe den protein, can ot be activat d d, herefore, cannot inhibit tissue 
calcifica ion [23,37,38]. 
Table 4. S mm ry of th re ults bt ed for each s rain comp red t the WT strain;  , decrease 
compared to WT st ain;  , increase fo  WT s rain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liv r    
In testis    
In kid ey    
In lung   = 
VKO C1 C CENTRATION 
In liv r    
In testis    
In kid ey    
In lung = = = 
VKORC1L1 C CENTRATION 
In liver = = = 
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being fu ther away fro  the latter [31]. Th se st ains re de ived fro t  OFA-Spra ue Dawley 
rat in whic  the mu a ed Vkorc1 g ne was i trodu ed with less than . 001% of the itial genome of 
the wild brown rat. We can, thus, l gitimately affect the pheno ypic odifications to the Vkorc1 
mu ation. 
We firs essed the i pact of the u ation on the ability of a h tiss e t  re ycle vit min K. 
F r this, w  measur VKOR act vit  from liver, k dn y, lung, nd t sticula  icr som s. VKORC1 
is localiz d in the membr ne of th  endoplasmic retic lum [2]. Th li er is respo sible for the 
activ tio  of fa tor  II, VII, IX, and X {2]. Th  kidney, lung, and te tis co ta n igh amounts of vita in 
 [32] d calcify trongly i  the bsence of vitamin K [23]. Regardless f th  tissue, mic somal 
VKOR t vity is lw ys greatly d cre ed wh n VKORC1 i  mu at d, r gardl ss of the positio  (i.e., 
amin  acid 120 or a ino acid 139) nd ature (wheth  a ino cid 139 is rep c  by phenylal la ine 
or cystei e) f the mu tion. Aff nity f r vitamin K d s not see  to b  m dified (K  u changed), 
but vel cit of R ct vity is ystem ticall gre tl  reduc d (b  a f ct r f 3 to 6 depending on 
the tissue a d the mu ation). T is loss of v locity may be due t   malfuncti n of VKORC1 due to 
mu ations d/ r a d c ea  in the VKORC1 xpress  l v l becau e f instability of the mu ated 
pro ei . The malfunction is c t in. The c ract rization o  the corr ponding recombi ant proteins 
has demonstrated t is loss of v l city [33]. On the th r and, t is study shows that the VKORC1 
expres io  l v l mains unchange  d spit  th  pr ence f mu ati ns L120Q, Y139F, or Y 39C 
regardl ss of tissu , xcept in the liv  of t e Y139F train w re VKORC1 is slightl  expresse . 
Expressi n of VKORC1L1, which is anoth r nzyme th t i  able o c talyz  VKOR act vity [34] and, 
thu , co pen ate for loss f VKORC1 act vity, lso remains u c anged exc p  i  lungs wh re its 
expr ssion is slightly i creased  compen a e for the l ss of act vity of VKORC1 in the lung. 
Th pr s c  of th e mutations in rats tha  n be co sid red l borat ry rat  llowed us o 
ppr ciat the con que ces of  de rea e i  VKOR act vity on the “vit in K” s atus (Table 4). This 
s atus w s evaluate  by d er ing tiss  vi i  conc ntr ti ns, easure e t of plasma ucOC 
conc ntr ti , an  d te ination of ti sue calcium l v ls. A ong th   vit mins, only MK4 was 
m sur  becau  the rat  u ed received, fro the age of 3 weeks up to 8 weeks, a diet supplem nt  
with enadi n  as their sol sourc  of vi a in  (th amo nts of vitamin K1 in the standard feed 
being li ited and provi d by the c real  inco por t ). The latt r r ce ved vi tually no vit mi  K1 
and, sinc  th re is no n gen us sy th sis of vitamin K1, vitami  K1 w s almost und tecta le in rat 
tis u s. Osteoc lci  is a vitamin K-dependent pr t in produce  ostly by ost oblasts [35]. In the 
absen e f vitamin K, the nce tration of ucOC increa es rapidly in plasm  [36] and is, th r fore, 
consid r d a good m rke  of over ll vitamin K atus. Tis ue c lcium concentrations have also been 
shown to be egatively corr lat d with th  vit min K s atus. I  the absen  f vitamin K, MGP, which 
is another vitamin K-depe dent protein, can ot be activated a d, th refore, cannot inh bit tissue 
calci ic ion [2 ,37,38].
Table 4. Su m ry f th re ults obt d for each strain compared to t T strain;  , decrease 
compa d to WT strain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In te tis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver    
In te tis    
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being furthe  a ay fro  th l tter [3 ]. Th e strains r  derived from the OFA-Spragu  Dawley 
r  in which th  mu ated Vkorc1 g ne was introduced with less ha  0.0001% f the i itial genome of 
the wild brown rat. We ca , thus, legit m el  affect the phe typic modifi ations to the Vkorc1 
mutation. 
W  first assess  the impact of h  utati n on the bility f each t ssue to recycl  vitamin K. 
For this, we easured KOR a tivity fro liver, kidney, lung, and testicula  icrosomes. VKORC1 
is localize  in th  me bra of th  n opla mi  reticulu  [2]. The liver is r spo sible for the 
activati of fa tors II, VII, IX, an  X {2]. The kidney, lu g, and te ti  contain high mounts of vita in 
K [32] and c lcify trongly n h  absenc  of vi n K [23]. Regardles  of the tissu , micr somal 
VKOR tivit  is alway greatly ecr s  when V ORC1  mu a ed, reg rdless of the position (i.e., 
a i  aci  20 r a i  cid 139) and atur (whether ino acid 139 is replaced by phenylal lanine 
or cysteine)  th  u a ion. Affinit  f r vita in K does ot s em to be modified (Km unchanged), 
b  l it  of VKOR ctivit is st matically gre tl  e ced (by a factor of 3 to 6 depending on 
th  tissue and t  mu ati ). Thi  oss f l city y be due t  malfunction of VKORC1 due to
mutations and/or a d cr  in the VKORC1 expr ssi  l ve  because of ins bility of the mutated 
pr te n . T  m lfu io  is i . T ch ra z tion of th  c rre ponding recombin nt proteins 
as demo s r e  i  loss of v loci [33]. On the oth r hand, t is study shows that the VKORC1 
xp ess on level r mains c nged d spite the presence of mutations L120Q, Y139F, or Y139C 
regardless of t  tissue, exc pt in t e liver of the Y139F stra n where VKORC1 is slightly expresse . 
Expressio  of VKORC1L1, whi h is another enzym that is ble to catal z VKOR activity [34] and, 
thus, omp n ate for loss of VKORC1 c ivity, als  remains unchanged xcept i  lungs where its 
ex re ion is slightly i r ase  to c mpe te fo  the loss of act vi y f VKORC1 in the lung. 
The prese c  of the  mutatio s in ra  h t can be con id red oratory rat  allowed us to 
appr iate the o seq ces f a de rea e in VKOR ctivity on the “vit in K” tatus (Table 4). This 
status w s evalua e  by determining tiss  v tami  K con entrati s, me s re e t of plasma ucOC 
conc ntration, and t r inat on f tis ue calci m lev ls. A ong the  vitamins, only MK4 was 
m asu d b ca s the t  u d received, fro  t e age of 3 w ks up to 8 weeks, a iet supple ent  
wi  e adi ne s t ir ole sourc  of vita in  (th  oun s of vi min K1 in the stand rd feed 
being limi ed an  p ovided by th  cereals inco p at d). The l ter receiv d virtually no vitami  K1 
and, i ce there   endoge us sy th i of vitamin K1, vitamin K1 was almost undetectable in rat 
ti ues. st o alcin is  vita i  K-d nd nt pro ein pr duc  mo tly by s eoblasts [35]. In the 
absenc  of itamin K, the once tr tion of u OC i cre s rapidly n plasma [36] and is, therefore, 
consid red  good mark  of overall vi amin K tatus. Ti sue alcium concentrations have also been 
s own to be n gati ely correlat d wi h th  vitami  K statu . In t e abse c f vitamin K, MGP, which 
is a oth r vitamin K-depe dent protein, ca not b  act vated and, t erefore, cannot inhibit tissue 
c lcifica i n [23,37,38]. 
Tabl  4. Summary o  th  r ul  ob a ed fo  ea str in comp re  to th  WT strain;  , decrease 
comp red to WT strain;  , incre e for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver =  = 
In testis = = = 
In kid ey    
In lung = = = 
VKO C1L1 CONCENTRATION 
In liver = = = 
In lung
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bei g furt er away from the latt r [31]. These strains ere e ive  fro  t e OFA-Sprague Dawl y 
rat in which the mu at d Vkorc1 ge  was introduc d wi  less than 0.0001% o  t e ini ial g n me of 
the wild brown rat. We ca , thus, legitimately affect the phenotypic modifications to the Vkorc1 
mutation. 
We first as e sed the impact of the utation o  the ability of ach tiss e to recycle vit min K. 
For this, we measured VKOR activity from liv r, kidn y, l g, nd testicular icro om . VKORC1 
is loc lized in the membrane of the endoplasmic reticulum [2]. The liver is resp n ible for the 
activation of f ctors II, VII, IX, nd X {2]. Th  ki ney, lu g, a d testis co t in hig  amounts of vitamin 
K [32] and calcify strongly in the absence of vi amin K [23]. R gar l ss of the tissue, mic osomal 
VKOR activity is lways greatly decre sed when V ORC1  mutat d, regardl ss of t  po ition (i. ., 
amino acid 120 or amino acid 139) and natur  (whether ami  cid 39 is replaced by ph ylalalanin  
or cyst ine) of the m tation. Affinity for vitami  K does not seem t  be dified (K  unchanged), 
but velocity of VKOR activity is syste tically greatly re ced (b   f ct r f 3 t  6 d pen ing  
the tissue an  the mutation). This loss of velocity ay b  du to a malfu ction of VKORC1 d  to 
mutation  and/or a d crease in t VKORC1 expressio lev l because f i stability of the mutated 
prot ins. The malfunction i  ce ain. The ch rac erization of the c rr sponding reco binant p otei s 
has d monstrat d this lo s f velocity [33]. On t  other ha d, this study shows that the VKOR 1 
xp ession lev l mains uncha g d despit  t  pr s nce f mutations L 20Q, Y139F, or Y 39C 
regardless f the tissu , xcept in the liver of t e Y139F strain where VKORC1 is slightly expre sed. 
Expression of VKORC1L1, which is an ther enzyme that is able to c talyze VKOR a tivity [34] and, 
thus, c mpensate for los  of VKORC1 a tivity, al o re ains unchanged except in lungs here its 
expression i  slightly increased to compe ate for the los  f activity of VKORC1 in the lung. 
The pres nce of th se utations in rats that can b  considered labor t ry r s allowed us o 
appreciate the cons quenc s of a decre e in VKOR a tivity o  the “vitamin K” status (Tabl  4). This 
status was evalu ted by determining ti sue vit mi  K concentr ti s, asure ent f plasma ucOC 
concent ation, nd dete ination of tissue calcium l vels. A ong th  K vitamins, only MK4 was 
measured because t e rats use  r ceived, fro  the ag  of 3 weeks up to 8 weeks,  di t supplement d 
with mena io e as their sole source of vitamin K (th  amounts f vitamin K1 i  the st ndar  feed 
being limited and pr vided by the cereal  incorporated). The l tter received vir ally no vit min K1 
and, ince th re is no endogen us sy the is of vitami  K1, vitamin K1 was al o t undetecta le i  rat 
ti su s. Osteoc lci  is a vitami  K-dependent protein produced ostly by osteobl st  [35]. In the 
ab ence of vitamin K, the concent ti  of ucOC increases rapidly in plasm  [36] and is, ther fo , 
c nsidered a good marke  of ov rall vitamin K status. Ti sue calcium concentr tions hav  also been 
shown to be negatively c rrelat d with th  vitamin K st tus. In the abs n e of it mi  K, MGP, which 
is another vitamin K-dependent protei , c nnot be activate  and, t erefore, cannot in ibit tissue 
calcific tion [23,37,38].
Table 4. Su ary of the results btained for ach strain compared t  he  str i ;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q 139F Y139C 
VKOR ACTIVITY 
In liver    
I  testis    
 kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
 testis = = = 
I  kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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bei g furt er away from t e latter [31]. Th e strains ere derived fro the OFA-Sprague Dawl y 
r t in which the mutat d Vkorc1 gen  was introduc d wit  less ha  0.0001% the ini ial g nome of 
the wild brown rat. We can, thus, legitimately affect the phenotypic modifications to the Vkorc1 
mutation. 
We first as e sed t e impact of the utation o  the bility f ach tissue to recycle vitamin K. 
For this, we measured VKOR a tivit  fro  liver, kidney, l ng, and testicular micro ome . VKORC1 
is localized in the membr  of the e opla mi  reticulum [2]. The liver is r sp n ible for t e 
activation of f ctors II, VII, IX, and X {2]. Th  kid ey, lu g, and t ti  contain hig  mounts of vitamin 
K [32] and calcify trongly in he absence of vi amin K [23]. R gar les  f the tissue, icros mal 
VKOR tivity is lways g eatly dec eased when V ORC1 is mutated, r g rdless of t  position (i.e., 
a ino acid 120 or amino cid 139) and ature (whethe  a i  acid 139 is rep ced by phe ylalalanine 
or cystei e) of the mut tion. Affinity for vitamin K does not seem to be m difi  (Km unchan ), 
b t velo it  of VKOR activit  is s tematically greatly re ced (by  f ctor f 3 t  6 depen ing n 
th  tissue an  t  t ti ). Thi  loss of loci y ay b  du  to a malfunction of VKORC1 d  to 
mu tio s a d/or a d cre s  in he VKORC1 xpression lev l because f instability of the mutated 
pro i s. Th  malfunction i  c tain. The c ar cterization of the corresponding recombinant protein  
has d monstr t  thi  lo s of v l city [33]. On t e other and, this study shows that the VKOR 1 
xp essio  lev l r m ins uncha g d d spite th  pre enc  of mutations L 20Q, Y139F, or Y139C 
regardless f t e tissu , xc pt in t e liver of the Y139F str in where VKORC1 is slightly expressed. 
Expression of VKORC1L1, which is another zyme that is able to c talyz  VKOR activity [34] and, 
thus, mp nsate for loss f VKORC1 activity, ls  re ains u chang d exc p  in lungs here its 
expr sion i  slightly i creased o c mpe a e fo the lo s f ctivity f VKORC1 in the lung. 
Th pres n e of th se utati ns in ra s that can be con idered l oratory r s allowed us to 
appr ciate the co que c s of  decrea e in VKOR tivity o  the “vita in K” st tus (Table 4). This 
status was evalu ted by de er ining ti sue vi min K conc ntrati s, m asure ent f plasma ucOC 
conc nt ation, nd etermination f ti sue calcium l ls. A ong the K vitamins, only MK4 w s 
m asu ed beca se t  r ts used received, f om the ag  of 3 weeks up to 8 weeks, a iet supplement d 
with mena i e as their sole sourc  of it min K (th a ou ts of vitamin K1 in the standard feed 
bei g limited and pr vided by the cereal  incorporated). The l tter rece v d ir ally no vit min K1 
a d, inc  th re is no nd gen us synthesis of vitami  K1, vitami  K1 w s al t undetectable i  rat 
ti u s. Ost oc lci  i  a vitami  K-d p nd nt pr tein produced ostly by steobl st  [35]. In the 
ab enc  of itamin K, the onc t ation of u OC increas s rapidly in plasma [36] and is, therefor , 
c nsidered  good m rke of overall vitami  K status. Ti sue calcium concentr tions have also been 
shown to be negatively correlat d with the vitami  K st tus. In the abs ce of vit mi  K, MGP, whi h 
is an ther vitamin K-depe dent pr tein, can ot be activate  a , t erefore, ca not in ibit tissue 
c lcific tion [23,37,38].
Table 4. Su ry of the results ob ained for ach strain comp r d to the  str i ;  , decrease 
compared to WT strain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q 139F Y139C 
VKOR ACTIVITY 
In liver    
I  testis    
 kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
 testis = = = 
I  kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
=
1 C CENTRATION
In liver =
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being further away from the latter [31]. These strains were derived from the OFA-Sprague Dawley 
rat in which the mutated Vkorc1 gene as introduced with les  than 0.0001% of the initial genome of
the wild brown rat. We can, thus, legitimately affect th  phenotypic modification  to the Vkorc1 
mutation. 
We first assessed the impact of the mutation o  the ability of each tissue to recycle vitamin K. 
For this, we measured VKOR activity from liver, kidn y, lung, and testicular microsomes. VKORC1 
is localized in the m mbrane of the endoplasmic reticulum [2]. The liver is responsible for the 
activation of factors II, VII, IX, and X {2]. The kidney, lung, and testis contain high amounts of vitamin 
K [32] and calcify strongly in the absence of vitamin K [23]. Regardless of the tissue, microsomal 
VKOR activity is always greatly decreased when VKORC1 is mutated, regardless of the position (i.e., 
a ino acid 120 or amino acid 139) and nature (whether amino acid 139 is replaced by phenylalalanine 
or cysteine) of the mutation. Affinity for vitamin K does not see  to be modified (Km unchanged), 
but velocity of VKOR activity is systematically greatly reduced (by a factor of 3 to 6 depending on 
the tissue and the mutation). This loss of velocity may be due to a malfunction of VKORC1 due to 
mutations and/or a decrease in the VKORC1 expression level because of instability of the mutated 
proteins. The malfunction is certain. The characterization of the corresponding recombinant proteins 
has demonstrated this loss of velocity [33]. On the other hand, this study shows that the VKORC1 
expression level remains unchanged despite the presence of mutations L120Q, Y139F, or Y139C 
regardless of the tissue, except in the liver of the Y139F strain where VKORC1 is slightly expressed. 
Expression of VKORC1L1, which is another nzy e that is able to cat lyze VKOR activity [34] and, 
thus, compensate for loss of VKORC1 activity, also remains unchanged xcept in lungs where its 
expression is slightly increased to compen ate for th  loss of acti ity of VKORC1 in the lung. 
The presence of th se m ta ions in rats that can be considered laboratory rats allowed us to 
appreciate the conseque ces of a de ase n VKOR activity on the “vitamin K” status (Table 4). Thi  
stat s was evalu ted by eter ining tissue vitamin K concentrations, measurement of plasma ucOC 
conce tration, and determination of tissue calcium levels. Among the K vitamins, only M 4 wa  
measured because the rats used received, from e age of 3 weeks up to 8 weeks, a die  supplemented 
with menadione as their sol  sourc  of vitamin K (the mounts of vit min K1 in the standard feed 
bei g li ited and p vi ed by the cereals incorporated). The latter received virtually no vitamin K1 
and, since there is no endogenous synthesis of vitamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitamin K-dependent protein produced mostly by osteoblasts [35]. In the 
absence of vitamin K, the concentration of ucOC increases rapidly in plasma [36] and is, therefore, 
considered a good marker of overall vitamin K status. Tissue calcium concentrations have also been 
shown to be negatively correlated with the vitamin K status. In the absence of vitamin K, MGP, which 
is another vitamin K-dependent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Sum ary of the results obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 TRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 C CENTRATION 
In liver = = = 
=
In testis = =
In kidney = = =
In lung = = =
1L1 C CENTRATION
In liver = =
In testis = = =
In kidney = = =
In lung
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being further aw y fro  the latter [31]. These st ins were derived from the OFA-Sprague Dawley 
rat in which the mutated Vkorc1 gene was introduced with less th n 0.0001% of the initial genome f 
the wild br wn rat. We can, thus, legitimately affect th  p enotypic modifications to the Vkorc1 
mutation. 
We first assessed the impact of the mut tio  on the b lit  of each issue to recycle vitamin K. 
For this, we measured VKOR activity from liv r, kidney, lung, an  testicular micr o es. VKORC1 
is localized in the embra  of t  endopl smic reticulum [2]. The liv r is responsibl  for the 
ac ivation of factors II, VII, IX, and X {2]. The kid ey, lung, and t stis c tain high amounts of vitamin 
K [32] and cal ify strongly in the absence of vitamin K [23]. Regardless of the tissue, icrosomal 
VKOR activity is always greatly decreased when VKORC1 is mutated, r gardless of the position (i.e., 
amino acid 120 or amino acid 139) d nature (wh ther amino acid 139 is replaced by phe ylalala in  
or cysteine) of the mutati n. Affinity for vitamin K does not seem to be modified (Km unchanged), 
but velocity of VKOR ctivity is systematically gre tly reduced (by  factor of 3 to 6 depe ding on 
th  tissu  and t  mut tion). This loss of velo ity may be due to a alfunction of VKORC1 due to 
mutations and/or a dec a e in the VKORC1 xpression level b cause of instability f the mutated 
proteins. The m lfunction is certain. The characterization of the correspon ing recombinant proteins 
has d monstrated this los  f vel city [33]. On the ther hand, this study shows that the  
expression level r mains unchanged despite the presence f mut tions L120Q, Y139F, or Y139C 
regardless of the tis ue, x ept in th  liver of the Y139F str in where V ORC1 is slightly expressed. 
Expre sion of VKORC1L1, which is another enzyme that is able to catalyze VKOR activity [34] and, 
thus, compensate for loss of VKORC1 activity, ls  remains unchanged except in lungs here its 
expre sion is slightly increased to compensate for th  loss of activity of VKORC1 in the l g. 
The presence of these mutations in rats th t can be considered labor tory rats allowed us to 
appreciate the consequenc s of a d cr ase in VKOR activity on the “vit min K” status (Table 4). This 
status was evaluated by deter ining tissue vita in  co centr tio s, e rement of plasm  ucOC 
concentration, and determin tion of tissue calcium levels. Among the K vitamins, only MK4 wa  
measured because the rats used received, from the age of 3 weeks up to 8 week , a diet supplemented 
with mena ione as their sol  s urce of it in  (the amo nts of vitamin K1 in the st ndard fe d 
being limited and provided by th  cereals incorporated). The latter received virtually no vitamin K1 
and, since there is no en og ous synth sis of vitamin K1, ita i  K1 was almost u detectable in rat 
tissues. Osteocalcin is a vitamin K-dependent protein produce  mostly by osteoblasts [35]. I  the 
absence of vitamin K, the conc ntrati n of ucOC in re ses a i ly in p ma [36] n  is, h r fo e, 
considered a good m ker f ov rall vit mi  K statu . T ssue calciu conce tratio h ve al o been 
shown to be negatively correlated with the vitamin K status. I  the absence of vitami  K, MGP, which 
is another vitamin K-dependent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the res lts obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with W  strain. 
 L120Q Y139F Y139C 
VKOR ACTI I Y 
In liver    
In testis    
In kidney    
In lung   = 
1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further aw y fro  the latter [31]. Th se st ains were derived from the OFA-Sprague Dawley 
rat in which the mutated Vkorc1 gen  was i troduced with les  than 0.0001% f t  initial genome of 
the wild br wn rat. We can, thu , le itimat ly affect the phenotypic odifications to the Vkorc1 
mutation. 
We first ass ss d the impact mutatio  on the ability f each tissue to recycle vitamin K. 
For this, we measured VKOR activit  from liver, kidney, lung, an  testicular microso es. VKORC1 
is loc lized i the mbr e of the end pl s ic reticulum [2]. The liver is responsible for the 
activation of factors II, VII, IX, and X {2]. The k dney, lung, and t stis contai  high amounts of vitamin 
K [32] and calcify trongly in the abs nce of vit in K [23]. Regardless f the tissue, microsomal 
VKOR activity is always greatly d creased when VKORC1 i  mutated, r gardless of the position (i.e., 
a ino acid 120 or amino acid 139) d ature (wh the  ami o acid 139 is rep ced by phe ylalalanine 
or cystei e) of the mutati n. Affinity for vita in K does not seem to be modified (Km unchanged), 
but velocit  of VKOR activity is systematically greatly r duced (by  factor of 3 to 6 depending on 
th  tissu  and th  mutati n). This loss of v locity may be due to a malfunction of VKORC1 due to 
mutations a d/or a decr as  in th  VKORC1 xpression level b c use of instability of the mutated 
pr ei s. The m lfunction is c tain. The c aracterization of the correspon ing recombinant proteins 
as demonstrated this loss of v l city [33]. On the ther and, this study shows that the VKORC1 
xpressio  level r mains unc anged d spite the pre ence f mutations L120Q, Y139F, or Y139C 
regardless of the tissu , x ept in th liver f t  Y139F strain where VKORC1 is slightly expressed. 
Expre sion of VKORC1L1, which is another nzyme that is abl to catalyze VK R activity [34] and, 
thus, compensate for loss of VKORC1 activity, lso remains u changed exc p  in lungs where its 
xpre sion is slightly i creased o compe sa e for the loss of activity of VKORC1 in the l ng. 
Th pre ence of these utations in rats that can be consider d laboratory rats allowed us to 
a pr ciate the cons que c s of a d cr ase i  VKOR activity on the “vitamin K” status (Table 4). This 
status was evaluated by de er ining tissue vi a in K conc ntrati ns, me ureme t of pl sma ucOC 
conc ntration, and determi tion of ti sue alcium levels. Am ng the K vitamins, only MK4 as 
m asur d be ause the rats sed received, from the age of 3 weeks up to 8 we ks, a diet supplemented 
with m na ione as their sole s urc  of vitamin K (the amo nts of vitamin K1 in the st ndard fe d 
being limited and provided by the cereal  i corporated). The latter rece ved virtually no vitamin K1 
and, sinc  th re is no en g us synth sis of vitamin K1, itamin K1 w s almo t undetectable in rat 
tis ues. Osteocalcin is a vitamin K-dependent pr tein produced ostly by osteoblasts [35]. In the 
absenc  of vitami  K, the onc tration f ucOC in e ses r idly in plasma [36] n is, th r fore, 
nsid red a good m ker f ov rall v tami K st us. Tissue lc u concentratio s have al o been 
shown to be negatively co related with the vitamin K status. I  the absence of vitami  K, MGP, which 
is another vitamin K-depe dent protein, can ot be activated a d, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summ ry of the res lts obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVI Y 
In liver    
In testis    
In kidney    
In lung   = 
1 C CENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away fro  the latt r [31]. Th se st ins were derived from the OFA-Sprague Dawley 
rat i  which the mutat d Vkorc1 gen  was int oduced with l s  than 0.0001% f th  i itial genome of 
the wild brow  rat. We can, thus, le t mately affect the p notypic odifications to the Vkorc1 
mutation. 
We f rst ass ss d the impa t of the mutation on the ability of each tissue to recycle vitamin K. 
For this, we measured VKOR activit  f o  liver, kidne , lu g, and testicular microsomes. VKORC1 
is l calized in th  me br ne of the endoplas ic reticulum [2]. The liver is responsible for the 
activation of factors II, VII, IX, and X {2]. The kidney, lung, nd testis contai  high amounts of vitamin 
K [32] and calcify trongly in he abs nce of vit in K [23]. Regardless f the tissue, microsomal 
 activity i  always gre ly d crease  when VKORC1 i  mutated, regardless of the position (i.e., 
a ino acid 120 o    ) and atu  (whethe  ami o acid 139 is rep ced by phenylalalanine 
or cystei e) of the mutation. Affinity for vita in K does not see  to be modified (Km unchanged), 
but velocit  of VKOR a tivity is sys ematically gr atly educed (by a factor of 3 to 6 depending on 
the tissue and the mut ti n). This loss of v locity ay be du  to a malfunction of VKORC1 due to 
mutations a d/or a d cr ase in th  VKORC1 xpression lev l bec use of instability of the mutated 
pr ei s. The malfunction is c tain. The aracterization f the corresponding recombinant proteins 
as demonst ated this loss of v locity [33]. O  t  other and, this study shows that the VKORC1 
xpressio  level r mains unc anged d spite the pre ence of mutations L120Q, Y139F, or Y139C 
rega dless of the tissu , except in the liver f t  Y139F strain where VKORC1 is slightly expressed. 
Expr ssion of V ORC1L1, which is another zyme that is abl to catalyze VK R activity [34] and, 
thu , co pensate for loss of VKORC1 activ ty, lso remains u changed exc p  in lungs where its 
xpression is sli htly i cr ased o co p n a e for the loss of acti ity of VKORC1 in the lu g. 
Th  pre ence of the e mutations in ats t at ca  be consider d l boratory rats allowed us to 
a pr ciate the cons que ces of a d cr ase i  VKOR ctivity on the “vitamin K” status (Table 4). This 
stat s was ev luated by de er ining tissue vi a in K conc nt ti ns, me surement of plasma ucOC 
conc ntr tion, and deter i ati n of ti sue alcium levels. A ng the K vitamins, only MK4 was 
m asur d b ause the rats sed received, from the age of 3 w eks up to 8 we ks, a diet supplemented 
with nadione as their sole sour  of vita i   (the amounts of vitamin K1 in the standard feed 
b ing limited nd provided by th  cereal  i corporated). The latter rece ved virtually no vitamin K1 
and, inc  th re is no e d ge us synthesi  of vitamin K1, vit mi  K1 w s almo t undetectable in rat 
tis ues. Oste calcin is a vita in K-depende t pr tein produced ostly by osteoblasts [35]. In the 
abse c  vit mi  K, the nce t ti n f ucOC increa es r pidly in plasma [36] and is, therefore, 
ns dered a good rk r of overall v tamin K st us. issue c lc um concentrations have also been 
show  to b  egatively co r l ted i  the vit min K status. In the absence of vitamin K, MGP, which 
is another vitam n K-dependent protein, t be ac ivated a d, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summ ry of the results obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , inc ease fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 C CENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
MK4 CONCENTRATION
In liver =
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being further way fr m the latter [31]. These strains were derived fr m the OFA-Spr gue Dawley 
rat in which th  mutated Vkorc1 gene was introduced with less an 0.0001% of the ini ial genome of 
the wild brown rat. We can, thus, legitimately aff ct the phenotypic modifications to the Vkorc1 
mutation. 
We first assessed the impact of the mutation on the ability of each tissue to recycle vitami  . 
For this, we measu ed VKOR activity from liver, kidney, lung, and testicular microsomes. VKORC1 
is localized in the membrane of the doplasmic reticulum [2]. The liver is respo sible for the 
activation of fa tors II, VII, IX, and X {2]. The k ney, lung, a d testis ntain high amounts of vitamin 
K [32] and calcify stro gly in th  absence of vitamin K [23]. R gardless of the issue, microsomal 
VKOR cti ity is al ays greatly d creas d when V ORC1 is utat d, regardless of the positi n (i.e., 
ami o acid 120 or amino acid 139) and nature (whet r amino acid 139 is repl ced by phenylalalanine 
or cystein ) of th  utation. Affin ty for vitamin K does not see t  be odified (Km unchang ), 
but vel c ty of VKOR ctivity is systematically gr atly reduced (by a fact r of 3 to 6 depen ing on 
the tissue and the m tation). This loss of velocity may be due o a malfunction of VKORC1 due to 
mu ations and/or a decrease in the VKORC1 xpression l vel because of instabilit  of the mutated 
proteins. The malfunction is certain. The characterization of the corresponding recombinant proteins 
has d mons rated this loss of veloc ty [33]. n the other h nd, th s study shows that the VKORC1 
expression level re ains unchanged despite the presenc of mutati s L120Q, Y139F, or Y139C 
regardless of the tissue, except in the liver of the Y139F strain where VKORC1 is slightly expressed. 
Expression of VKORC1L1, which is another enzyme that is able to catalyze VKOR activity [34] and, 
thus, compensate for loss of VKORC1 activity, also remains unchanged except in lungs where its 
expression is slightly increased to compensate for the loss of activity of VKORC1 in the lung. 
The presence of these mutations in rats that can be considered laboratory rats allowed us to 
appreciate the consequences of a decrease in VKOR activity on the “vitamin K” status (Table 4). This 
status was evaluated by determining tissue vitamin K concentrations, measurement of plasma ucOC 
concentration, and determination of tissue calcium levels. Among the K vitamins, only MK4 was 
measured because the rats used received, from the age of 3 weeks up to 8 weeks, a diet supplemented 
with me adion  as their sole source of vitamin K (the amounts of vitamin K1 in the standard feed 
being limit d and provided by the cereals incorporated). The latter received virtually no vitamin K1 
and, since her  o endogenous nthesis of vitamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitamin K-dependent protein produced mostly by osteoblasts [35]. In the 
absence of vitamin K, the conce tration of ucOC increases rapidly in plasma [36] and is, therefore, 
considered a good marker of overall vitamin K status. Tissue calcium concentrations have also been 
shown to be negatively correlated with the vitamin K status. In the absence of vitamin K, MGP, which 
is another v tamin K-dependent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Tab e 4. Summary of the results obtained for each strain compared to the WT strain;  , decrease 
compared to WT strain;  , increase for W  strain; =, similar with W  strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away from th latter [31]. T se strains were derived from the OFA-Sprague Dawley 
ra  in which the mutated Vkorc1 g ne was introduced wit  les t  0.0001% of the initial genome of 
the wild brown rat. We can, thus, legitimately ffect the phen typic modifications to the Vkorc1 
m tation. 
W  first assessed the impact of the muta i n on th  ability of each t ssue to recycle vitamin K. 
For this, we measured VKOR ctivity from liver, kidney, lung, and t sticula  microsomes. VKORC1 
is lo alized in the embrane f the endoplasmic reticulum [2]. The liver is r sponsible for the 
activation of f ctor  II, VII, IX, and X {2]. The kidney, lung, n  tes is con ain high amounts of vitamin 
K [32] and lcify stro gly i  h  absence of v t min K [23]. Regardless of the tissue, microsomal 
VKOR activit  is always gre tly decreas d wh  VKORC1 is u a ed, regardless of the position (i.e., 
a i  aci  20 or a ino a id 139) and nature (whether amino aci 139 is replaced by phenylalalanine 
or cystein ) o  the mutati n. Affinity for vit i K do s not s em to be modifie  (Km unchanged), 
bu  ve oci y f VKOR ctivit  is syste atically gre tly reduced (by a fac or of  to 6 depending on 
the t ssu  nd the mutation). This loss f velocity y be du to a malfunction of VKORC1 due to 
mutation  a d/or a decrease in the VKORC1 exp e si n level because of inst bility of the mutated 
prote s. Th  malfunction is ertain. The chara te ization of th  c rre ponding recombinant proteins 
has dem stra ed his loss of velocity [33]. On the other hand, t is study sh ws that the VKORC1 
exp essi n level re ains unc anged despite the presence of mut tions L120Q, Y139F, or Y139C 
r gardless of the tissu , except in the liver of the Y139F strain where VKORC1 is slightly expressed. 
Expr ssion of VKORC1L1, which is another e zyme that is able t  catal ze VKOR activity [34] and, 
thus, compensate for loss of VKORC1 ctivity, also remains unchanged except in lungs where its 
expression is slightly increased to compens te for the loss of act vi y of VKORC1 in the lung. 
The presence of these mutatio s in rat  that can be c nsidered aboratory rats allowed us to 
appreciate the consequ nces of a de rease in VKOR activity on he “vit min K” status (Table 4). This 
status was evaluated by deter i ing tissue vitamin K concentrations, measurement of plasma ucOC 
concentration, and determinat on of tis ue calcium levels. A ong the K vitamins, only MK4 was 
measured b caus  the rats used received, from the age of 3 weeks up to 8 weeks, a iet supplemented 
wi  menadion  as their sole source of vitamin K (the amounts of vi min K1 in the standard feed 
being limited and p ovided by the cereals incorpo at d). The latter received virtually no vitamin K1 
a d, since there  no endogenous synthesis of vitamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitamin K-de endent protein produc d mo tly by os eoblasts [35]. In the 
absence of vitamin , the concentration of uc C i cre es rapidly in plasma [36] and is, therefore, 
consid ed a good marker of overall vitamin K status. Tissue calcium concentrations have also been 
shown to be n gatively correlated wi h the vitamin K status. In the absence of vitamin K, MGP, which 
is anoth r vitamin K-depe dent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the r sult  obtained fo  each strain compared to th  WT strain;  , decrease 
compared to WT strain;  , increa e for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away from the l t er [31]. Th se strai s w re derived from the OFA-Sprague Dawley 
r  in which the mu ated Vkorc1 g ne was introduced with less than . 001% of the nitial genome of 
the wild brown rat. W  can, thus, legitimatel  affect the phe otypic modifi ations to the Vkorc1 
mu ation.
We f rst as ess d the impact of the mu ation on the ability of each tissue to re ycle vitamin K. 
For this, we meas r d VKOR act vity from liver, ki ney, lung, and testicular micr somes. VKORC1 
is loc liz d in the membrane of th  endoplas c retic lum [2]. The liver is respo sible for the 
activation of factors II, VII, IX, and X {2]. The kid ey, lu g, and te tis contain h gh amounts of vitamin 
K [32] a d calcify trongly n the ab e ce of vita in  [23]. Regardl ss of the tissue, micr soma  
VKOR act vity is lways grea ly decreased when VKORC1 i  mu ated, regardless of the position (i.e., 
ami o acid 120 or amino cid 139) and nature (whether amino acid 139 is replaced by phenyl l la ine 
or cysteine) of th  mu a ion. Aff nity for vita in K do s not s em to be odified (Km unchanged), 
but velocity f VKOR ct vity is st matically greatly educed (by a factor of 3 to 6 depending on 
the tis ue nd th  mu ati ). This loss of velocity may be due to a malfunction of VKORC1 due to 
mu atio s and/or a decrease in the VKORC1 expr ssio  l ve  becaus  of i s ability of the mu ated 
prote . The malfu tion is cert in. The h ract rization f the correspon ing recombi ant proteins 
as dem nstrated this loss of velocity [33]. On the other hand, thi  s udy shows that the VKORC1 
expression l vel re ains unchange  despite the pr sence f mu ations L120Q, Y139F, or Y139C 
regardless of the tissu , except in the liver of the Y139F str n wh re VKORC1 is slightly expressed. 
Expr ssio  of VKORC1L1, which is another enzyme that is able to c talyze VKOR act vity [34] and, 
thus, compensate for loss of VKORC1 act vity, also remains unchanged xcept in lungs wh re its 
expression is slightly incr ased to c mpensate for the loss of act vity of VKORC1 in the lung. 
The pr sence of th e mu ations in rats that can be consid red laboratory rats allowed us to 
appre iate the consequences of a decrease in VKOR act vity on the “vitamin K” atus (Table 4). This 
s atus was evalua ed by d term ing tissue v tamin K concentrations, me s rement of plasma ucOC 
concentration, an  d t rmination of tissue calcium l vels. Among the  vitamins, only MK4 was 
measured because the ats us d r ceived, from the age of 3 weeks up to 8 weeks, a diet supplemented 
with menadione as their sole source of vitamin K (the amoun s of vitamin K1 in the standard feed 
being limit d and provi ed by th  c reals inco porated). The l tter r ceived virtually no vitamin K1 
and, since h re is no endogenous synthesis of vitamin K1, vitamin K1 was almost und tectable in rat 
ti sues. Osteocalcin is a vitamin K-depend nt pro ein pr duced mostly by osteoblasts [35]. In the 
absence of vitamin K, the concentr tion of ucOC increa es rapidly n plasma [36] and is, th refore, 
consid red a good marker of overall vitamin K s atus. Tissue calcium concentrations have also been 
shown to be negatively correlated wi h the vitamin K s atus. In the absence of vitamin K, MGP, which 
is another vitamin K-dependent protein, c not b  activated and, t refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Tabl 4. Su mary o  th  results obtained for eac  strain compare  to the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In te tis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In te tis = = = 
In kidney = = = 
In lung = = = 
VKO C1L1 CONCENTRATION 
In liver = = = 
In testis =
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being further away from the latter [31]. These strains ere e ive  fr m t e OFA-Sprag  Dawley 
rat i  whic  the mu ted Vkorc1 e was ntrod ced with less than 0.0001% of t e i i ial gen me of 
the wild brow  rat. We ca , thus, egitimately affect he phenotypic modif cat ons to the Vkorc1 
mutation.
We first ssess  the impact f the atio  on th  ability of each tiss e to recycl vit min K. 
Fo  th s, we measured VKOR activity from li e , kidn y, lu g, d testicula  icrosom s. VKORC1 
is localized i  the membra e of the e doplasmic re iculum [2]. The liver is respo sible for h  
acti a io  of fa ors II, VII, IX, nd X {2]. The ki ney, lung a d testis co tain high amounts of vita in 
K [32] nd calcify strongly in t e b ence of vita i  K [23]. Regardl s  of th  tissu , ic os al 
VKOR tivity is lways gre tly decre ed when VKORC1 is utat d, regardless of th  po ition (i. ., 
amino acid 120 or a ino aci  139) and nature (w ether amino c  139 is r place  by phenylal la i  
or cystei e) f he t ti . Affinity for vita in K does n t seem to be o ifie  (Km u c ang ), 
ut locity of VKOR ctivity is yst tically greatl  reduc d (b   factor of 3 to 6 epend g  
the t ssue a d the mutati n). This loss of velocity may be due to  alfunction of V ORC1 due o 
m tations a d/or a d crea e the VKORC1 expr ssi  level ecau e f i stability of the mutat d 
proteins. The alfu cti n is ain. The c aracterization of the corr onding recomb ant proteins 
ha  mo strate  this lo  f elocity [33]. On the th r hand, t is study shows that the VKORC1 
expressi n l vel ains unchang d d spit  the pr s nce f utations L120Q, Y139F, or Y 39C 
regardl ss of the tissu , except in the li er of t e Y139F strain where VKORC1 is slightly expr se . 
Expressi  of VKORC1L1, which is an ther enzyme that is able to c talyz  VKOR a tivity [34] and, 
thus, compen ate for lo  of VKORC1 a tivity, also re ains unchanged except i  lungs where its 
expression is slightly increased to c mpen ate for the los  of activity of VKORC1 in the lung. 
The presence of th s  mutations i  rats that c n be co sid red l borat ry rat  allowed us o 
appreciate the consequences of a decrea e in VKOR activity on the “vitamin K” status (Tabl  4). This 
status w s evaluate  by determi ing tiss  vit mi  K concentr tions, easure e t of plasma ucOC 
concentration, and d te mination of tissue calcium levels. A ong th  K vitamins, only MK4 was 
measur d because the rat  use  rec ived, fro  the ag  of 3 weeks up to 8 weeks, a diet supplement  
with me adion  as their sol  source of vitamin K (th  amounts f vit min K1 in th  stand r  feed 
being limit d and provi ed by the cereal  incorporated). The latter received virtually no vit mi  K1 
and, since there is o endogen us s th is of vitamin K1, vitamin K1 was almost undetecta le in rat 
tis ues. Osteocalcin is a vitamin K-dependent protein produce  mostly by osteoblasts [35]. In the 
absenc  of vitamin K, the concentration of ucOC increases rapidly in plasma [36] and is, th r fo e, 
considered a good marke  of overall vitamin K status. is ue c lcium concentrations hav  als  been 
shown to be negatively c rrelated with th  vitamin K status. In the absen  f itamin K, MGP, which 
is another vi amin K-depe dent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the re ults bta ed for each strain compared t the WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver    
In testis    
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being furt er awa  from th latter [31]. The e strains ere d rived from the OFA-Spragu  Dawley 
r  in hic  the mut ted Vkorc1 g e was introd ced with l ss ha  0.0001% of the i itial genome f 
the wild br w  rat. We can, thus, legit mately affect the phe typic modifications to the Vkorc1 
mutation. 
W  first ass s  the impact f the utati n o  th  bility f ach t ssu  to recycl  v tamin K. 
For this, we measur d VKOR activity f m liver, kid ey, lung, a d testicula  microsomes. VKORC1 
is localized in the embra e of the nd pla mi  reticulum [2]. The liver is r spo sible for the 
activatio   fa t rs II, VII, IX, a d X {2]. The kidney, lung, a d testi  contain high mounts of vita in 
K [32] nd calcify stro gly i   abs nc  of vi min K [23]. Regardles  of th  tissu , micr s mal 
VKOR tiv t  is always gr atly dec ea ed wh n VKORC1 is uta ed, reg rdless of the position (i.e., 
a i  aci  20 r a ino cid 139) a d nature (whether a i o a id 139 is r placed by phenylal l ine 
r ystein )  mut tio . Affinit  f r vita i  does not s m to be o ifie  (Km unchanged), 
but elocit of VKOR c iv t  is y te atic lly gre tl  reduc  (b a factor of 3 to 6 depending on 
the tissu  a d t  mutati n). This loss of locity y be due to  malfunction of VKORC1 due to 
mut tio s and/or a d cr e in he VKORC1 ex ressi  level b aus  of inst bility of the mutated 
prote ns. Th  m lfuncti n i  ertai . The chara te izati n of th  c rre pon ing combinant proteins 
has d mo str ted his loss f v locity [33]. On t e oth r hand, t is study hows that the VKORC1 
expr ssion l vel r ai s unc anged d spite the presence of utatio s L120Q, Y139F, or Y139C 
regardl ss f e tissue, xc p i  t e li er of the Y139F strain where VKORC1 is slightly expresse . 
Expres i n of VKORC1L1, which is another e z me that is able to atal z  VKOR activity [34] and, 
thus, omp n ate for los  of VKORC1 ctivity, als  r mains unchanged except i  lungs where its 
xpression is slightly i creased to compens te fo  the loss of ct vi y of VKORC1 in the lung. 
The pr senc  of thes  mutatio s in rat  that c n be con id r d oratory rat  allowed us to 
appreciate th  co sequ nces of a de rea e in VKOR activity on he “vit in K” status (Table 4). This 
status w s evaluate  by deter ining tiss  vitamin K concentrations, measure e t of plasma ucOC 
concentration, and d t rminat on of tis ue calcium levels. A ong the K vitamins, only MK4 was 
measu d b ca s  the rat  used receiv d, fro  the age of 3 weeks up to 8 weeks, a iet supplement  
wi  menadion  as their sole sourc  of vitamin K (the amounts of vi min K1 in the stand rd feed 
bei g limit d and p ovi ed by the cereal  inc rpo t d). The latter r ceived virtually no vitami  K1 
a d, since there i  o endogenous sy th sis of vitamin K1, vitamin K1 was almost undetectable in rat 
tis ues. Osteocalcin is a vitamin K-de dent protein produc  mo tly by os eoblasts [35]. In the 
abse c  of vit min , the concentration of uc C i cre s rapidly in plasma [36] a d is, therefor , 
consid red  good marke  of overall vitami  K status. Tis e calcium co ntrations have also been 
show  to be n g tively correlated wi h the vitamin K status. In the abse c  f vitami  K, MGP, which 
is anoth r vitamin K-depe dent protein, cannot be activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the r ult  ob a ed fo  each strain comp red to th  WT strain;  , decrease 
compared to WT strain;  , increa e for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liv r    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liv r    
In testis    
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being furt er away from t e l tter [31]. Th se strains re derived from t e OFA-Spra u  Dawley 
r  i whic th  mu ated Vkorc1 g e was introduced with less than . 001% f the itial genome of 
the wild brown rat. We can, thus, legitimatel  affect the phe ot pic modifi ations to the Vkorc1 
mu atio . 
We first es  the impact of the ati  n the ability f ea h tissue t  re ycl  vitamin K. 
F r thi , we measur d VKOR a t vity fro li er, kid ey, lung, and sticula  icr somes. VKORC1 
is lo lized in the membra  of  e opla mic retic lum [2]. Th  liver is respo sible f r the 
activ tio of fa tor  II, VII, IX, an X {2]. The kidney, lu g, and te tis co tain igh a unts of vita in 
 [32] nd calcify tro gly n the abse ce of vita in K [23]. Regardless of the tissu , micr somal 
VKOR vity  always g tly decre sed whe  VKORC1 i  u ated, r g rdle s of the positio  (i.e., 
amino aci  120 r a in  cid 139) and ature (whether a i o acid 139 is place by phenylal la ine 
r cystein ) f t e . Aff ity for vita in K do s not se m t  be m dified (Km u change ), 
b t veloc ty of VKOR t vit  i  st atically greatl ed c d (by a factor of 3 to 6 dependi g on 
th  tissue and the mu ati n). T i  loss f velocity may be d e to  malfunction of VKORC1 due to 
m atio s a d/or a ecre  i  the VKORC1 xpr ssi  l ve  ecau e of i s ability of the mu ated 
prot in . Th  alfu tion is c rt in. The ch ract riz tion f the corre onding recombi ant proteins 
as em strat  thi  loss of velocity [33]. On t e th r hand, this study shows that the VKORC1 
expr s ion l vel remai s unchange  d spite th  pr ence of mu ations L120Q, Y139F, or Y139C 
regardless of the tissue, except in t e liv of the Y139F tra  wh re VKORC1 is slightl  expresse . 
Expressi  of VKORC1L1, which is another enzym  th t i  able to c talyz VKOR act vity [34] and, 
thu , compen ate for loss of VKORC1 act vity, also remains unchanged xcept i  lungs wh re its 
expr sion is slightly incr ased t c mpe ate f r the loss of act vity f VKORC1 in the lung. 
Th  pr se  of th  mu ations in ra s that n be consid red l boratory rat  llowed us to 
ppre iate the conseq ences of a decrea e in VKOR act vity on the “vit in K” atus (Table 4). This 
s atus w s ev lua e  by d term ing tiss  v ta in K concentrati s, me s re e t of plasma ucOC 
concentration, an  t r ination f tissue calcium l v ls. Among the  vit mins, only MK4 was 
measur  becau e the t  u d ceived, fro the age of 3 weeks up to 8 weeks, a diet supplem nt  
with enadione as their sole source of vit min K (th  amoun s of vitamin K1 in the stand rd feed 
bei g limit d and provi d by th  c real  inco porated). The l tter r ceiv d virtually no vitami  K1 
and, since th re is o endogen us synth sis of vitamin K1, vitamin K1 was almost und tectable in rat 
ti u s. Ost ocalcin is a vitami  K-d pend nt pro in pr duce  mostly by steoblasts [35]. In the 
absenc  of itamin K, the c ncentr tion of u OC increa es r pidly n plasm  [36] and is, th r fore, 
consid r d a good marke  of overall vitamin K s atus. Tis ue calcium concentrations have also been 
shown to be negatively corr lated wi h the vitamin K s atus. In the absenc f vitamin K, MGP, which 
is another v tamin K-dependent protein, c not b  activated and, t refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Tabl 4. Su mary  th re ults obta d for eac  strain compare  to t e T strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In te tis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver    
In te tis    
In kid ey    
In lung = = = 
VKO C1L1 CONCENTRATION 
In liver = = = 
In kidney
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being further away from the latt r [31]. The e str ins w r  riv  fr m t e OFA-Sprag e Dawley
at in which the mu at  Vkorc1 g wa  introduced wi h less t an 0.0001% of t e n ial g m  of
the wil  br wn rat. We ca , t us, legi im t ly affect the phenot pic m dific tio s to the Vkorc1
m tati n. 
We f rst as ess d the impact f th  mut ti n n the ability f eac  tis ue t  recycl  vita in K.
For this, we measured VKOR activity from liv r, kid ey, lung, an  testicular mic osomes. VKORC1
is localiz d in the m mbr ne of th  dopl ic reticulum [2]. The li er is r sponsi f r the
activation of f ct rs II, VII, IX, and X {2]. The ki y, l ng, a d tes is co t in high m ts of vit in
K [32] and calcify strongly in the bsence of vi a i K [23]. R gardl ss of the ti sue, icr s l
VKOR activity i  alw ys g atly ecr s  when VKORC1 is mutat , regar l s  f th  p ition (i. .,
amino acid 120 r a i o aci  139) and a ur  (w ethe  a ino acid 139 is r placed by p nylalala i
or cystei e) of the tatio . Affi ity for ta in K do s n t see  t  b fi d (Km u changed),
ut velocity of VKOR act vity is syste atically gr atly reduced (by  factor of 3 t  6 p ing
he tissue and the mut ti n). T s loss of v loci y y b   t a a fu ctio  f V ORC1 due t
mutations and/or  d cr a e in the V ORC1 expr ssio  level because of i stability of the mutated
proteins. The malfu ction is cer ai . The c aracteriz ti  of th rresp di g r c bi a t p otei s
has demonstrat t is o  f eloc y [33]. O the othe  a d, is study shows t t t  VKORC1
expressi n le el re ai s uncha g d d spi e the pr s nce of muta io s L120Q, Y139F, or Y139C
reg rdless of the tissue, xcept in the liver f the Y139F strai  where VKORC1 is slightl  expre sed. 
Expression f ORC1L1, which is an ther enzyme that is able t  c talyze VKOR a tivity [34] and, 
thus, compensate for los  of VKORC1 activity, al o re s unch nged ex ept in lungs where its 
expression is slightly increased to ensate for the los  f activity of VKORC1 in the lung. 
The presence of th se mutations in rats that can b  co sidered labor tory rats allowed us t  
appreciate the consequences of a decre se in VKOR activity on the “vitamin K” status (Tabl  4). This 
status was evaluated by determi ing tissue vitamin K concentratio s, easurement of plasma ucOC 
concentration, and deter ination of tissue calcium lev ls. Among the K vitamins, only MK4 was 
measured because the rats use  received, fro  the age of 3 we ks up to 8 w eks,  diet supplemented 
with menadion  as their sole source of vitamin K (the amounts f vit min K1 i  th  standar  feed 
being limited and provided by the cere ls i corporated). Th  latter received virtually no vit min K1 
and, since there is no endogenous synthe is of vitamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitamin K-dependent protein p oduced mostly by steoblasts [35]. In the 
absence of vitamin K, the concentrati  of ucOC increases rapidly in plasm [36] and is, ther fo e, 
considered a good marker of overall vitamin K status. Tissue calcium concentrations hav  also been 
shown to be negatively c rrelated with the vitamin K status. In the absence of itami  K, MGP, which 
is another vitamin K-depe dent protein, c nnot b  activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the results btained for each strain compared t  he WT strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139  
VKOR ACTIVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away f m the latt r [31]. Th se strains w re e iv d fr m t OFA-Sprag e Da ley
t in which the m t d Vkorc1 g n w s introduced w h less an . 001% f  niti l ge ome of
the w ld br wn rat. We can, thus, le i i ately affect the ph otypic modifications o t  korc1
m ati . 
We fir t s essed the impact of the u ati on the abili  f each ti s e to re cle vit min K. 
For this, we measured V OR ct vit  from iv r, kid y, lu g, n  testicular ic som s. VKORC1
is loc iz in the membra f th  d pl smic tic lum [2]. Th  liver is r ponsi f r the
ctivatio  of f c ors II, VII, IX, nd X {2]. The ki ney, lu g, a  te tis co t i  high am unts of vita i
K [32] and c lcify s ro gly  the ab nce of vita K [23]. R gardl ss of the ti s e, ic o l
VKOR act vity is lw y gr atly dec eased w en VKORC1 is at d, r gardl ss of the osition (i. .,
amino acid 120 or a no aci  139) and nat r  (w et er a in  cid 139 is replace  by phenyl l la e
or cystei e) of the u atio . Aff nity for tamin K es n t s em o b  d fied (K  u cha g d),
ut velocity of VKOR act vi y is yst m t call  g atly r duce (b  a fac r of 3 t 6 d pending o
he tissue and the m ti ). This l ss of locity ay b  o a a function f V ORC1 du  t
mu ati ns and/or a d cr ase i  the V ORC1 expressio  l v l b aus  f i st bilit  of th  u ated
prot ins. The malfu ction is ce t i . The c rac riz ti  f the c rr sp di g rec mbi ant p t i s
has demonstr te  this l ss f eloc y [33]. On the h r ha d, t is study ows t at the VKORC1
expressi n l vel ains unch nge es it  the r s ce f muta ions , Y139F, r Y 39C
regardless of the tissu , except in the liver of t e Y1 9F strain re VKORC1 is slightly expressed. 
Expression of VKORC1L1, which is another enzym  that is able to c talyze VKOR ct vity [34] and, 
thus, compensate for lo s of VKORC1 a t vity, a o re ai s unchanged except in lungs wh e its 
expression is slightly increased to compen ate for the loss of ct vity of VKORC1 in the lung. 
The pr sence of th se mu ations in r s t at can b  co sid re  labor t ry rats allowed us o 
appreciate the consequences of a decre e in VKOR act vity on the “vitamin K” s tus (Table 4). This 
s atus was evaluated by d term ing tissue vit mi K concentr tions, mea ur ment of plasma ucOC 
concentration, an  d te mination of ti sue calcium lev ls. A ong the K vita ins, only MK4 was 
measured because the rats used r ceived, fro  the ag  of 3 weeks up to 8 weeks, a diet supplemented 
with me adione as their sole source of vitamin K (th  amounts of vitamin K1 i  the st ndard feed 
being limit d and provi ed by the c reals i corporated). The latter r ceived virtually no vit min K1 
and, since th re is no endogen us sy th is of vita in K1, vitamin K1 was almost und tecta le in rat 
tissues. Osteocalcin is a vitami  K-dependent protein produced mostly by osteoblasts [35]. In the 
absence of vitamin K, the concentrati  of ucO  increa es rapidly in plasm  [36] and is, th refore, 
consid red a good marker of overall vitamin K s atus. Tissue c lcium concentrations have al o been 
shown to be negatively correla ed with th  vitamin K s atus. In th  absen  of vitami  K, MGP, which 
is another vitamin K-depen ent protein, c n ot be activated and, th refore, cannot inh bit tissue 
calcification [2 ,37,38]. 
Table 4. Su mary of th  results obtained for each strain compared o he WT str in;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In te tis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In te tis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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b ing fur r way f om e l te  [31]. T s r ins r  deriv d f m the FA-Spragu  Dawl y 
rat in whi h t e mutat d Vkorc1 g s i troduced w t  l ss an 0.0001% the initial g om  of 
the wil  br wn r t. W  can, thus, legi i t ly affec the phen typ c modifications to he Vkorc1 
m tati n. 
W  fir t a s s d t e ac f th  utati t e ability of a tis ue to recycle vitamin K.
Fo  thi , we m sured VKOR c iv t fr  l v , ki y, l ng, a d testicul r micr ome . 1
is loc liz d in the embr ne of th dopla ic ret culum [2]. The liv r is r p nsi l  for t e 
c ivatio f f ctors II, VII, IX, d X {2]. Th  kid ey, lung, and es s co i h g  a ts of vitamin 
K [32] and c lcify ro gly  he bsence of vit in K [23]. Regar l ss f the t ue, micro omal 
VKOR ctivi y is alw ys g atly d r ased whe V ORC1 i uta d, reg rdle s of the p sition (i.e., 
a no acid 120 or a i o acid 139) and nat re (w ethe  a i  acid 139 s r p c d by phenylal la i e 
o  cyst e) f mut ti . Affi ity for t in K do  t se m to b  if  (Km u ch ged), 
ut velocit  of VKOR ac vity s syste atic lly greatly re uced (by  f tor of 3 6 d pendi g n 
the tissue and the t ti n). This l ss f locity may b   to a malfuncti  f VKORC1 d e o 
mutations a d/or  decr as i  th  VKORC1 xpr s io  l vel ec use f inst bility f the mutated 
pr ei s. The m fu ction s c ta . e c ara te izati  f the c rresp di g combinant prot in  
has d m nstrat  this l f l city [33]. O   o her a d, this st dy sh ws that t  VKORC1 
xpressi  level re  u cha g d d spit  th  pre enc of uta io s L120Q, Y139F, or Y139C 
regar less of he issu , except in the live  of the Y139F strain wh re VKORC1 i  slightly expressed. 
Expression f VKO C1L1, which is ano her nzyme hat is ble to c talyze VKOR activity [34] and, 
thus, c mpensate for lo  f VKORC1 activity, lso ai  u chang d exc p n lungs here its 
expression is slightly i cre s d o c mpe sa e for the lo s of ct vity of VKORC1 i  the lung. 
T pres nce of th se mut i ns in rats that c n e considered laboratory r s allowed us to 
appr ciate the con que ces of  decrea e i  VKOR ctivity o the “vitamin K” st tus (Table 4). This 
s atus was valu ted by d er ining tissu  vi mi  K conc ntrati s, m asurement f plasma ucOC 
conc nt at on, d determin tion of ti sue calcium l els. A g the K vitamin , only MK4 w s 
m asured because the rats used received, f o th  age of 3 weeks up to 8 weeks, a diet supple ent d 
with menadi n  as th ir sole sourc  of itamin K (t  amou ts of vitamin K1 in the standard feed 
being l mited and pr vided by t e cereals i c rporated). T e l tter rece ed irtu lly no vit min K1 
and, sinc  th re is no nd genous sy thesis of v tamin 1, vitami  K1 w s al t undetectable i  rat 
tis u s. Osteoc lci  i a vitamin K-d pend nt pr t in pr duced mostly by osteobl sts [35]. In the 
absence of vitamin K, the once t tion of ucOC increases rapidly in plasma [36] nd is, therefor , 
considered a good m rker of ov rall itamin K st tus. Tissue calciu  concentratio s h ve also been 
shown t  b  negatively correl t d with the vitami  K st tus. I  he absence of vitami  K, MGP, whi h 
is another vitamin K-depe de protein, can ot be activat d d, herefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. S m ry of the results obtained for ach  comp r d to the WT strain;  , decrease 
compared to WT st ain;  , increase fo  WT s rain; =, similar with WT strain. 
 L120Q 139F Y139C 
VKOR ACTIVITY 
In liver    
I  testis    
In kidney    
In lung   = 
VKO C1 C CENTRATION 
In liver =  = 
 testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 C CENTRATION 
In liver = = = 
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bei g furt r away f m e l tt  [31]. Th se st ins re erived fr th OFA-Sprague Dawl y 
r t in which t  Vkorc1 g n was introduc d w h le s an . 001% of the ni ial g nome of 
the wild brown r t.  can, u , l gitimatel  ffect the phe o p  modifications  th  korc1
mu atio . 
W  fir  as ess d t  imp ct f th u ation  the abili y f ach ti sue to re cle vitamin K. 
For t i , w  mea ured VKOR c vit  fr  l v , k dney, l g, an  testic lar micr omes. VKORC1 
is lo liz d in the membrane of th  e doplasmic ret c lum [2]. Th  liver r sp ible for t e 
activation f factors II, VII, IX, a d X {2]. Th  kid ey, lu g, a d tis cont hig  a unt  of vita i  
K [32] a d c lcify stro gly n h  ab ce f vitamin K [23]. R ardless   tissue, icr so al 
VKOR ct vity is lw ys greatly d cr a d when VKORC1 i a ed, r g rdl ss f  osition (i.e., 
amino aci 120 or amino aci  139) nd at re (w et e ino acid 139 is ep c by he ylal la e 
 cyst i ) f the mu ati n. Aff nity for vi in K do s n t se to be mo ifie  (Km u changed), 
ut velocit of VKOR act vi y i s ticall  gre tly r ced (by  f ctor f 3 to 6 depen g n 
th  tissue an th  ti n). This loss f elocity may b  du  o a alfu c ion of VKORC1 du  t  
mu ati s a d/or a decr as  the V ORC1 xpress on l v l b cause of inst bilit  of t  u at d 
p o i s. The m fu ction i c in.  c ra eriz io  of the orresponding recombi nt pr tei  
as dem str te t is loss f l city [33]. O t e other hand, t i study h s t t the VKOR 1 
xp essi  l v l re i  u ch ng  d s ite the r nce of utat n  L 20Q, , or Y139C 
regardl ss f tissu , except in the liver of the Y139F str i  w re VKORC1 is slightly expressed. 
Expression of VKORC1L1, which is anoth r nzyme that is able o c talyze VKOR act vity [34] and, 
thu , c mpensate for los  f VKORC1 act vity, ls  re ains u chang d exc p  in lung  wh re its 
expr ssion i slightly i creased o c mpensa e for the lo s f ct vity of VKORC1 in the lung. 
Th pr se ce of th s utati s in rats that can be consid red laboratory rats allowed us to 
appr ciate the con que c s of  d crease i  VKOR t vity on the “vitamin K” s tu  (Table 4). This 
s atus was evaluated by d er ing ti sue vi amin K conc ntrati ns, ea ure e t f plasma ucOC 
conc ntr ti , an  d termination of ti sue calcium l els. A ong the  vit mins, only M 4 w s 
m sured becaus  t  rats used r c ived, f m the age of 3 weeks up to 8 weeks, a diet supplemented 
with me a i e as their sole source f i amin K (the mou ts of vitamin K1 in the standard feed 
being limit d and provi d by the c real  inco porat ). The latter r ce ved ir ally no vita in K1 
and, inc  th re is no nd genous synthesis of vitami  K1, vitami  K1 w s almost und tectable in rat 
ti ues. Osteocalcin i a vitami  K-depend nt pr tein prod ced ostly by osteoblast  [35]. In the 
ab en e of vitamin K, th  onc tration of ucO increa es rapidly in plasma [36] and is, th refore, 
c nsid red a good m rke  of ov rall itamin K s atus. Ti sue calcium concentr tio s have also been 
shown to be negatively co rela ed with the vit mi K s atus. In the abs nce of vit mi  K, MGP, whi h 
is another vitamin K-depe ent protein, can ot be activated a d, th refore, cannot inh bit tissue 
calcific tion [2 ,37,38].
Table 4. Su m ry of th  re ults obtained for each strain comp r d to th  str ;  , decrease 
compa d to WT strain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
In liver    
In te tis    
 kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In te tis = = = 
I  kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being fur r ay from th  la er [31]. Th  s ins re d rived f om the FA-Spragu  Dawley 
r  n hic  e mut t d Vkorc1 ge e s troduced w th l ss a  0.0001% f the i itial g nome f 
th  w ld br wn r . We can, thus, g t mat ly ffe the ph notypic modifications to he Vkorc1 
mutation. 
We f rst a s s e the mpac  f u ation o t  bility f ea h tissue to recycl  vitamin K. 
F t is, we asur d KOR ac i  f  liver, kid ey, l ng, nd testicula  microsomes. VKORC1 
i  local z d in the br ne of the d plasmi  reticulum [2]. he liver is respo sible for the 
ac ivatio f f t rs II, VII, IX, a d X {2]. The kid ey lu g, nd s  co ain h g  mounts of vita in 
K [32] and calcify ro gly  he abs nc  of vi amin [23]. Regardl ss f th  t u , micr s mal 
VKOR tivi y is always gre ly d eas wh n V ORC1 is utated, reg rdle s of the position (i.e., 
no ac  120 or   ) and nat re (w he  i  acid 139 s rep ced by phenylal l ine 
r cyste e) f e utat on. Affin ty f r t i   do s t se m t  b  odif  (Km unch nged), 
bu vel cit  f V OR vity is ys e at c lly gr a l re uc d (by a f ctor of 3 o 6 depending on 
th  tissu nd t  mutati n). This loss f locity a  e  t   malfunctio  of VKORC1 due o 
muta io s and/o   d cre se i  th  VKORC1 x res io  l v l aus of inst bility of the mutated 
pr i s. The m lfunctio  i t . The c ar cte iz ti  f th corre pon ing combinant proteins 
as dem str ted is loss f v l i y [33]. O e o h r and, this study h ws that the VKORC1 
xpressi l v l i u cha ged d spite the pr nce of utatio s L120Q, Y139F, or Y139C 
r ga less of e issu , xc pt i  t e live  of the Y139F strain where VKORC1 i  slightly expresse . 
Expr ssi n of VKORC1L1, which is ano her z me hat is able to atalyz  VKOR activity [34] and, 
thus, mp n ate for loss f VKORC1 activ y, ls  r mains u chang d exc p lungs where its 
xp ssion is slight y re s d o compensa e fo  the loss of activity of VKORC1 in the lung. 
T  pr sen  of the mut ions in ats that c n  con id r d l oratory rat  allowed us to 
appr ciate th co s que ces of a decrea e in VKOR ctivity on the “vita in K” status (Table 4). This 
s at w s valuate  by d er ining tiss  vi mi  K conc ntrations, measure e t of plasma ucOC 
conc nt t on, a d d t r in tion of ti sue calcium levels. A o g the K vitamin , only MK4 was 
m asu d b ca s  the rat  used receiv d, fro th  age of 3 w eks up to 8 weeks, a iet supple ent  
with menadi ne as their sole sourc  of vitamin K (the amounts of vitamin K1 in the stand rd feed 
b i g l mit d nd provi d by th  cereal  inc rpor ted). The latter r ce ed virtually no vitami  K1 
a d, inc  there is o nd genous sy thesi  of v tamin K1, vit mi  K1 w s al ost undetectable in rat 
tis u s. Os e ca c is a vita in K-dep dent pr tein produce mostly by osteoblasts [35]. In the 
bse c of vit min K, the once tration of ucOC increas s rapidly in plasma [36] a d is, therefor , 
considered  good m rke of overall vitami K st tus. Tis e calcium co entratio s have also been 
show  t  b  eg tively corr l ted with the vitamin K status. In he abse c  f vitami  K, MGP, which 
is another vitamin K-dependen prot in, t be ac iva d d, herefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. S mm ry f the re ults ob a ed for each s ain comp red to the WT strain;  , decrease 
compared to WT strain;  , inc ease fo  WT s rain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liv r    
In testis    
In kid ey    
In lung   = 
VKO C1 C CENTRATION 
I  liv r =  = 
In testis = = = 
In kid ey    
In lung = = = 
VKORC1L1 C CENTRATION 
In liver = = = 
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b ing f rt r a ay fr m t lat er [3 ]. Th se st ins re derived fr m t e OFA-Spra  Dawl y 
rat whic mu at d Vkorc1 g e wa ntroduc d with l s  t an . 001% f the itial genome of 
the wild bro r . W can, u , l g t matel  ffect the pheno pic modifications to the Vkorc1 
mu ation. 
We f r e   mpact f th  u ation n the abili y f a h tissue t  re ycl  vitamin K. 
F  t is, w measur d KOR a vit  f  liver, k dney, l g, and t sticula  micr omes. VKORC1 
i  l aliz d i  h  m br  of h e opla c retic lum [2]. h liver i respo sible for the 
activatio  f fa t rs II, VII, IX, a X {2]. Th  kidney, lung, d te tis cont n ig  amount  of vita in 
 [32] a d ca cify stro gly in  abse ce of vitamin  [23]. Re a dless f the tissu , micr somal 
VKOR t vity is l ays gre ly d c ed whe V ORC1 i  u ated, regardl ss of he osition (i.e., 
a ino ac 120  o  ) d ature (whe er o acid 139 is rep c by phe ylal la ine 
r cystei ) f e ti n. Aff n ty for vit min K do s not se  to be dified (Km u change ), 
b t ve cit of V OR t vit i s e icall gr l  red c d (by a factor f 3 to 6 depend g on 
the tissue a d the mu ati n). T i  loss f ve ocity ma  b du  to  malfu ction of VKORC1 due to 
m tati s a d/ r  cre  i  th  VKORC1 xpr ss  l v l becau e of instability of the mu at d 
pro ei s. Th  alfunction s c tain. Th  c ract riz ti n f the orre onding recombi ant protei s 
as em stra e hi loss of v l i y [33]. O oth r and, t i  study s ows that the VKORC1 
xpr s i n l v l r m i s c ange  d spite the p ence of mu ati ns L120Q, Y139F, or Y139C 
r ga dl ss of  tissu , except in t e liv  of t e Y139F trai  w re VKORC1 is slightl  expresse . 
Exp ssi  of VKORC1L1, which is anoth r nzym  th t i  able o c talyz  VKOR act vity [34] and, 
thu , co pen ate for loss of VKORC1 act v ty, lso rema ns u changed exc p  i  lungs wh re its 
expr si n is slightly i cr ased compen a e for the loss of act vity f VKORC1 in the lung. 
Th  pr se  of th ut ti ns in a s that n be consid red laboratory rat  llowed us to 
ppr ciate the cons que c s of  decrea e i  VKOR ct vity on the “vit in K” s atus (Table 4). This 
s at s w s ev luated by d er ing tiss  vi a in K conc ntrati s, easure e t of plas a ucOC 
conc ntr ti , an  termination f i sue calcium l ls. Among the  vit mins, only MK4 was 
me sur  b cau  the r t  u ed ceived, fro the age of 3 w eks up to 8 weeks, a diet supple nt  
with enadi ne as their sole sourc  of vi min K (th a ounts of vitamin K1 in the stand rd feed 
b i g limited nd provi d by th  c real  inco porat ). The latter r ce v d virtually no vitami  K1 
and, inc  th re is o nd gen us ynth si  of vitamin K1, vi mi  K1 w s almost und tectable in rat 
tis u s. Ost calcin is a vita i  K-d pendent pr t in produce  ostly by steoblasts [35]. In the 
absen  of itamin K, the nce tration of u O increa es r pidly in plasm  [36] and is, th r fore, 
consid r d a good m rke  of overall vit mi K s tus. Tis ue calcium concentrations have also been 
s own to be egatively corr l ted with the vit min K s atus. In the absenc  f vitamin K, MGP, which 
s another vitamin K- ependent protein, t be ac ivat d a d, th refore, cannot inh bit tissue 
c lcification [2 ,37,38]. 
Table 4. Su m ry f th re ults obta d for ach train compared to t T strain;  , decrease 
compa d to WT strain;  , inc ease fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In te tis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver =  = 
In te tis = = = 
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
In lung
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b i g furt r away f om the l t er [31]. The e s rains re ive fro  t OFA-Spragu Dawl y 
rat in which mu t d Vkorc1 ge  was i tr du d w t l ss an 0.0001% o  t in i l g n m  of 
the wild br wn rat. W  can, t u , legitimat l  ffec the ph otypic odific o s o h  korc1
mutati .
We fir t e s d i c  f t utation th  abili y f ti ue to rec c e vitami K.
For t is, w  m asured VKOR c v ty from liv r, ki n y, l g, d testicular icro m . 1
is lo lized in th  m mbr  of th ndopla c re icul m [2]. The liver i  sp n ible fo  th  
a tiva ion f fact rs II, VII, IX,  X {2]. Th  k dney, lung, a d s s c t i hig am u t  of ita i  
K [32] an lcify s ro gly he bse e of mi K [23]. Re ar less f th t s u , mic oso l 
VKOR activity is l ys g e tly d r sed whe  VKORC1 is u at d, regar l s f ition (i. .,
a o aci  120 or a o aci 139) and natur  (whet i  id 139 s r pl ced by h ylal la  
or cyste n ) of the tati n. Affi t f r tami   does not s m t  b odif d (Km unch ge ), 
but veloci y of VKOR act i  i s e atically great y  (  f cto  f 3 6 depen g  
th  tissue an  the m ta ion). This loss of l ci y ay b du  a ma functi n f VKORC1 d   
m tations nd/ r a d cr a e i  the V ORC1 ex r sio  l vel be a se of i t bil t  of th utat d 
pr t ins. Th alfu cti n i c ain. T e cha ac iz ion f t e rres ondi g co bina t protei s 
s m ns rat d this lo  f v l ci y [33]. O t  ther h nd, t i s y hows t a t  VKOR 1 
xp ess  lev l ai s u ch g d des it  th  r s nce f utatio s L 20Q, Y139F, or Y 39C 
regardless of the tissu , xcept i  the liver of t e Y139F str in where VKORC1 is slightly expr sse . 
Expressi  of VKORC1L1, which is an ther enzyme that is able to talyze VKOR a tivity [34] d, 
thus, c mpensate for lo  of VKORC1 a tivity, also re ai s unchanged exc pt in ungs where its 
expression i  slightly increased to c mpe ate fo  the los  f activity of VKORC1 in the lu g. 
The pr s nce of th se mutations in ats that can be considered labo at ry ra s allowed us o 
appreci te the cons quenc s of a decrea  in VKOR a tivit  o  the “vitamin K” status (Tabl  4). This 
status was evalu ted by determining ti sue vit mi  K concent ti s, asure nt f plasma ucOC 
concent ation, nd dete mination of tis e calcium levels. A ong th  K itamins, only MK4 as 
measured because t  rats used rec ived, fro  the ag  of 3 w ek  up t  8 weeks, a diet supple ent d 
with mena io e as their sol  source of vita in K (th  am unts f vit min K1 in th  stan ar  feed 
being limited and pr vided by the cereal  incorporated). The l tter received vir ally no vit min K1 
and, ince th re is no endogen us synthesis of vitami  K1, vit min K1 was alm t u det cta le i  rat 
ti su s. Osteoc lci  is a vitami  K-dependent protei  produc d mostly by steobl st  [35]. In the 
ab ence of itamin K, the conc nt tion of ucOC increases rapidly in plasma [36] and is, th r fo , 
c nsidered a good marke  of ov rall vitami  K status. Ti sue lcium concentr tions have ls  bee  
shown to be gatively c rrelat d with th  vitami  K st tus. In the abs n e f it min K, MGP, which 
is another vitamin K-depe de t protein, cann t be activate  and, t eref re, cannot in ibit tissue 
calcification [23,37,38]. 
Table 4. Su ary of the results btained for ach strain compared t the str i ; , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q 139F Y139C 
VKOR A TIVITY 
In liver    
I  testis    
 kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
 testis = = = 
I  kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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b i g f rt r way from t l t r [31]. The e s rai s re de v  fr  t e OFA-Sprag e Dawl y
r t i  wh c  mu at Vkorc ge  wa  tr d d wi  les ha 0.0001% t ini ial g n me of
e wild br w rat. W ca , t u , l git mat l  affec  the phe o pic modif ca ons to he Vkorc1
mutation. 
We fir  a e ed the i p  f h t tio n the bili y f h ti ue to ecycle vit min K.
F r t is, w  measu d KOR a v t  fr li er, ki n y, l g, d esticular icro om s. VKORC1
i  lo liz d in th  m mbr n  f h  n pla reticul  [2]. he li er i  esp n ible fo  th
activation of fact r  II, VII, IX, X {2] Th  k d ey lu g, d  co t in hig  m u t of vitamin
K [32] a d cal ify rongly  h bs nc  of vi a i [23]. R ar les  f he t s ue, ic osom l
VKOR tivity is l ays gre ly d sed when V ORC1 is utat d, r g rdle s of  o ition (i. .,
no aci  120 or a o ci  139) n tur (wh  i i 139 s rep c by ph ylal la in
r cy te ) f the utat . Aff t f r vita K do s n  m o b if e  (K  unch nge ),
b t elocity f VKOR ctivit  s t c lly greatl reduced (b   f cto f 3  6 depen g 
the tissue  t  mutation). Th  lo s of locit   du to a alfu ction of V ORC1 d  o
ta ions a d/   d cr i  th  VKORC1 x r s ion l v l ecau f i bil ty of the mutat d
pr ei s. Th  alfu cti n c in. The c cterization of the orr onding eco bi a t prote s
as m str e  i lo s f v lo i y [33]. O  t  th and, t i  study s ows th t t  VKOR 1
xp essio  l v l ains uncha g d d spit  t  p nce f u atio s L 20Q, Y139F, or Y 39C 
regardless of t e tissu , xc pt i  t e li er of t e Y139F strain where VKORC1 is slightly expressed. 
Exp essi  of VKORC1L1, which i  an th r zym  that is ble to c talyz  VKOR a tivity [34] and, 
thus, mp nsate for lo s of VKORC1 a tivity, ls  re ai s u changed exc p  i  lungs where its 
xpre sion i  slightly i creased o co pe a e fo the los  f activity f VKORC1 in the lung. 
Th pr s n  of th se mutations in ra s that can be co idered l orat ry ra s allowed us o 
appr ci te the co s q e c s of a decrease in VKOR tivity o  the “vita in K” status (Tabl  4). This 
status was evalu ted by de er ining ti sue vi mi  K conc ntr ti s, asure ent f plasma ucOC 
conc nt ation, nd etermination f ti sue calcium l v ls. A ong th  K vitamins, only MK4 was 
measu ed beca se t e r ts use r c ived, fro the age of 3 weeks up to 8 weeks, a i t supple ent d 
with mena i e as their sole sourc  of vit min K (th  amounts f vit min K1 in th  standar  feed 
bei g limited and pr vided by the cereal  incorporated). The l tter rece v d vir ally no vit min K1 
a d, inc  th re is no nd gen us sy the is of vitami  K1, vitamin K1 w s alm t undetecta le i  rat 
ti u s. Ost oc lci  is a vitami  K-d p ndent pr tein produced mostly by steobl st  [35]. In the 
ab enc  of itamin K, the onc t tion of u OC increas s rapidly in plasma [36] and is, th r fo , 
c nsidered  good m rke of ov rall vitami  K status. Ti sue c lcium concentr tions hav  also been 
shown to be gatively c rrelat d with th  vitamin K st tus. In the abs e of it min K, MGP, which 
is another vitamin K-depe de t pr tein, can ot be activated a , therefore, ca not inhibit tissue 
calcification [23,37,38]. 
Table 4. Su ry of the results b ained for ach strain comp red t  the  str i ;  , decrease 
compared to WT strain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q 139F Y139C 
VK R A TIVITY 
In liver    
In testis    
 kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
n testis = = = 
I  kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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b ing furt e a ay f om h l t  [31]. Th se s r ins re d riv d f om the FA-Spragu Dawl y 
ra  n h t mut ed Vk rc1 g e wa ntrodu d with l ss tha 0.0001% of the i itial g n me f 
the wild br wn r . W  can, t us, gi m tel affec th phen typ c modifica io s to he Vkorc1 
utati n. 
W  fi t s s t  mp c  f h ut ti n  th bility of ch t ssue to recycl  vitamin K. 
For thi , w  su d KOR c iv ty f m l v , ki y, l ng, and testicula  micr somes. VKORC1 
is local zed th m mbrane f th d pl ic ret c l  [2]. The li r is r p sible for the 
ivatio  f fa t r  II, VII, IX, d X {2]. T e kid y, lung, nd  cont in hig  mounts of vita in 
K [32] an c lcify s ro gly  he abs nc of v t min  [23]. Regardless f th t u , micr s mal 
VKOR tivit  is alw y  g atly re s d wh n VKORC1 i uta d, regardle s of t  position (i. ., 
a c  20 or a ino aci 139) nat re (w her  acid 139 s repl c  by phenylal l ine 
 cy t ) ut o . Affin t  f r i K do s ot em to b  odif ed (Km unch nged), 
bu  vel cit  f V OR cti it  s ystematically gr l re uced (by a fa tor of 3 6 depending on 
th tissu a d th  muta i n). Th  s f elocit  y b du to  malfunctio  of VKORC1 due o 
tat a d/ r decr se i  the VKORC1 ex ressi  l v l b s of inst bil ty of th mutat d 
pr t ns. Th m fu ction  ai . e c ra e z ti  of t c rre pon ing ecombinant proteins 
as dem s ra ed his l ss f vel it [33]. O  e t r h nd, t is s udy h ws that the VKORC1 
express  l v l rem s u c g d d spite t  presence of uta io s L120Q, Y139F, or Y139C 
regar l ss of the tissue, except i  t e liver of the Y139F str in where VKORC1 is slightly expresse . 
Exp ssi  of VKORC1L1, w i  i  a other e z m  th t i  able to atal z  VKOR activity [34] and, 
t us, compen ate f r loss of VKORC1 ctivity, lso r mains u c anged except i  lungs where its 
ex res ion is slightly in reased to comp ns te for the l ss of act vi y of VKORC1 in the lung. 
Th  pr sen e of th s  mutatio s i  ra  t at c n b  con id r d boratory rat  allowed us to 
ppr ciat  th  consequ nces of a d rea e i  VKOR ctivity on he “vit in K” status (Table 4). This 
stat  w s evaluat  by d ter ining tiss  vitamin K concentr tions, measure e t of plasma ucOC 
concentration, nd d t rminat on of tis ue calci m lev ls. A ong the K vitamins, only MK4 was 
m asur d b caus  the rat  used received, fro  the age of 3 w ks up to 8 weeks, a iet supple ent  
wi  menadio e as their sol  sou  of itamin K (the mounts of vi min K1 in the stand rd feed 
bei g limit d nd p ovi ed by the cere l  inc rpo t d). The lat er received vi tu lly no vitami  K1 
and, inc  ther  o oge ou s nthesis of vitamin K1, vitamin K1 was al ost undetectable in rat 
tis ues. Osteo alcin i  a vitami  K-d e dent protein produc  mostly by os eoblasts [35]. In the 
abse c  f vit min K, the once tratio  of u OC i cr es rapidly in pl sma [36] a d is, therefor , 
consid r d a good mark  of ov rall vitamin K t tus. Ti e calcium co entrations have also been 
s ow  to be neg tively correlated wi h the vit min K status. In t e absenc  f vitami  K, MGP, which 
is a oth r vitamin K-depe dent pr tein, cann t be act vated an , therefore, ca ot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summ y of th re ult  obt ed fo  each str in compared to th  WT strain;  , decrease 
comp red to WT strain;  , incre e for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VK R ACTIVITY 
I  liv r    
In testis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liv r    
In testis = = = 
In kid ey    
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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b i g fu t er a ay f m  l t [3 ]. Th e str ins r  der ved fr m t e OFA-Spra u Dawley 
r  i hic muta d Vk rc1 g e wa r du d with le s than . 001% of the tial genome of 
the wild brown r . W  an, u , l gitimatel  ffect th  phe ot p c modif ations to the Vkorc1 
u on.
W  fi t e  th p t f th u ti n  the abili y of a h tissue t  re yc  vitamin K. 
F r t i , w  m a r KOR c vity f m l v , kidn y, l g, and t sticula  micr omes. VKORC1 
i  lo alized th  m br ne f th  e doplas ic ret c lum [2]. The li er respo sible for the 
ctiv ion f fa t r II, VII, IX, a X {2] T e kid y, lu g, d e tis cont in ig  am unt  of vita in 
[32] d ify stro gly  th ab c  f vit n  [23]. R ardless f h  t ssu , micr somal 
VKOR t vi y is al ys grea ly d cr d whe V ORC1 u a ed, r gardless of he osition (i.e., 
mi o c 120 r a ino acid 139) a d nat re (wh r o cid 139 is eplac by phe ylal la ine 
 cy t in ) f  n. Aff ty f r vi in K d s se m o b  dified (Km u change ), 
but vel ci  f V OR ct vit i s m ically gre ly e e (by a factor f 3 to 6 depend g on 
th tis ue a d th mutati n). T i s f v ocity m y b du to ma fu c ion of VKORC1 due to 
t s a d/or  e e the VKORC1 xpre si  lev  becaus  of i s bility of the mu at d 
p ot in . The fun i n c rt i . h ch ra t riz io f the orre onding recombi ant protei s 
s m s ra ed is loss f v l i y [33]. O   oth  hand, t i  study shows that t e VKORC1 
expres  l v l rem i s u c ange  d pite t  pr nce of mutat ons L120Q, Y139F, or Y139C 
rega dless of the tissu , xc pt in the liv of the Y139F tr  wh re VKORC1 is slightl  expresse . 
Expr ssi  of VKORC1L1, w ich is anothe  enzyme t t i  ble to c talyz VKOR act vity [34] and, 
thu , c pen at for los  f VKORC1 ac vity, also remains u c anged xcept i  lungs wh re its 
expre ion is slightly in r ased t c mpen te for the l ss of act vity of VKORC1 in the lung. 
Th  pr s  of th  u ations in rats th  n be con id red laboratory rat  llowed us to 
ppr i t  the c equences of a d rea e in VKOR ct vity o  the “vit in K” atus (Table 4). This 
at s w s ev lua ed by d ter ing tiss  v ta in  con entrations, me s re e t of plas a ucOC 
conc ntration, an  d t rmination of tissue calcium l v ls. Among th   vit mins, only MK4 was 
measur  becau the at  u d c ived, fro  the age of 3 w eks up to 8 weeks, a diet supple nt  
with e adion  s their ol  source of it mi  K (the a o n s of vitamin K1 in the stand rd feed 
being limited an  provi d by th  c real  inco p r ted). The l tt r r ceived vi tually no vitami  K1 
and, since th r is o ogenou  s nth sis of vitamin K1, vitamin K1 was almost und tectable in rat 
ti ues. Osteocalci  i a vita i  K-depend nt pro in produce  ostly by ost oblasts [35]. In the 
abse c  f vitamin K, the c ncentr tio  of ucOC incr a es r pidly n pl sm  [36] and is, th r fore, 
consid r d  good marke  of ov rall vi a in  atus. Tis ue calcium concentrations have also been 
show  t  be eg tively corr lat d wi h the vitamin K s atu . I the absenc f vitamin K, MGP, which 
is an ther vita in K-dependent pr tein, c not b  activated an , t refore, ca not inh bit tissue 
c lcification [2 ,37,38]. 
Tabl 4. Su m ry  th e ults obt d for ea  strain compare  to t e T strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY 
I  liver    
In te tis    
In kid ey    
In lung   = 
VKORC1 CONCENTRATION 
I  liver    
In te tis = = = 
In kid ey    
In lung = = = 
VKO C1L1 CONCENTRATION 
In liver = = = 
PLASMA ucOC
CONCENTRATION =to
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being further away from the latter [31]. These strains were derived from the OFA-Sprague Dawley 
rat in which the mutated Vkorc1 gene was introduced with less than 0.0001% of the initial geno e of 
the wild brown rat. We can, thus, legitimately affect the p e otypic modifications to the Vkorc1 
mutation. 
We first assessed the impact of the mutation on the ability of each tissue to recycle vitamin K. 
For this, we meas red VKOR activity from liver, kidney, lung, and testicular microsomes. VKORC1 
is localized in the membra e of the endoplasmic reticulum [2]. The liver is responsible for the 
activation of factors II, VII, IX, and X {2]. The kidney, lung, and testis contain high amounts of vitamin 
K [32] and calcify stro gly in the absence of vitamin K [23]. Regardless of the tissue, microsomal 
VKOR activity is always greatly decreased when VKORC1 is mutated, regardless of the position (i.e., 
amino acid 120 or ami o acid 139) an  nature (whether ami o acid 139 is replaced by phe ylalalanine 
or cysteine) of the mutation. Affinity for vitamin K does not seem to be modified (Km unchanged), 
but velocity of VKOR activity is systematically gre tly reduced (by a factor of 3 to 6 depending on 
the tissue and the mutation). This loss of velocity may be d e to a m lfunct on of VKORC1 due o 
mutatio s and/or a decrease in the VKORC1 expression level b cause of instab lity of the mutated 
proteins. The malfunction is certai . The c aracterization of the corresponding recombinant proteins 
has demonstrated this loss of velocity [33]. On the other hand, this study shows that the V ORC1 
expression level remains uncha ge  despite the presence of mu ations L120Q, Y139F, or Y139C 
regardless of the tissue, except in the liver of the Y139F s rain where V ORC1 is sl ghtly expressed. 
Expression of VKORC1L1, which is another enzyme that is able to catalyze VKOR activity [34] an , 
thus, compe sate for loss of VKORC1 activ ty, also re ai s unchanged except in lungs where its 
expression is slightly increased to compe sate for the loss of activity of VKORC1 in the lung. 
The presence of these mutations in rats that ca  be considered l boratory ats allowed us to 
appreciate the co sequenc s of a dec ease i  VKOR activity o  the “vitamin K” status (Table 4). This 
status was evaluated by determining tissue vitamin K concentratio s, measure ent of plas a ucOC 
concentration, and determination of tissue calcium levels. Among the K vitamins, only MK4 was 
measured because the rats use  re eived, f o  the age of 3 we k  up to 8 week ,  diet suppleme ted 
with me adione as their sole source of vitami  K (the amou ts of vitamin K1 in the standard feed 
being limited and provided by the cer als incorporated). The latter received virtually no vitamin K1 
and, si ce there is no endogenous synthesis of vitamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitami K-dep ndent pro ein p o uc mostly by osteoblas s [35]. In the
absence of vitamin K, the concentratio  of ucOC increases apid y in plasma [36] and is, therefore, 
considered a good marker of o all vitamin K status. Tissue calcium concentrations have also been 
shown to be negatively correlat d with the vitamin K status. In the absence of vitamin K, MGP, which 
is another vitamin K-dependent protei , ca ot b  activated and, therefore, cannot inhibit tissue 
calcification [23,37,38]. 
Table 4. Summary of the results obtained for each strain compared to the W  strain;  , decrease 
compared to WT strain;  , increase for WT strain; =, similar with WT strain.
 L120Q Y139F Y139C 
VKOR AC IVITY 
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being fur r away from the la ter [31]. hese strains were erived f om the OFA-Sprague Dawley 
rat i  which t e mutated Vkorc1 ge e as introduced with less t an 0.0001% f the initial genome of 
the wild brown rat. We c n, thus, legitimately affect the phenotypic mo ifications to the Vkorc1 
utation. 
We first assessed the i pact f t  mutation o  the ability of ea h tissue to recycle vitamin K. 
Fo  this, we measured VKOR activity from liver, kidney, ung, and testicular microsomes. VKORC1 
is localized in the m mbrane of th  endoplasmic r ticulum [2]. The liver is responsible for the 
activation of f ctors II, VII, IX, a d X {2]. The kidney, lung, and testis co tai h gh amounts of vitamin 
K [32] and calcify stro gly in the absence of vitami  K [23]. Regardless of the tissue, microsomal 
VKOR activi y is alw ys greatly decreased when VKORC1 is mutated, regardless of the position (i.e., 
a ino acid 120 or a i o acid 139) an ature (w ether amino acid 139 is rep ced by phenylalalanine 
or cysteine) of t e m tation. Affinity for vi amin K do s not seem to be modifi  (Km unchanged), 
but velocity of VKOR ac vity is systematically greatly reduced (by a factor of 3 to 6 depending  
t e tissue and the m tati n). This loss of ocity ay be due  a m lfu ction of VKORC1 due to
mutations and/or a decrease in th  VKORC1 ex ression level because of instabil ty of the mu ated 
proteins. The m lfunction s erta . The characte izati  of the correspo ding r combinant proteins 
has demonstrated this loss of veloci y [33]. On t e o her hand, this study shows that the VKORC1 
expression level r mai  unch ged despite the prese ce f mut ti s L120Q, Y139F, or Y139  
regardl ss of he issue, except in the live  of the Y139F  where VKORC1 is slightly expressed. 
Expression of VKORC1L1, w ich is another nzyme that is able to catalyze VKOR activ ty [34] and, 
th s, compensate for loss of VKORC1 activity, also r mains unchange  exc pt in lungs where its 
expression is slightly incre s d to compensate for t e loss of activity of VKORC1 in the lung. 
T  presence of thes  m t ti s i rats th t can e nsidered laboratory rats allowed us to 
appreci t  the conseq ences of a d crease in VKOR activity on the “vit min K” status (Table 4). This 
s atus was valuated by determi ing tissu  vit mi  K concentrations, measurement of plasma ucOC 
co c nt at on, a d determin tio of tissue calcium l vels. A o g the K vitamin , only MK4 was 
measured because t e rats used received, from the ge of 3 weeks up to 8 weeks, a diet supplemented 
with me ad on  as their sole source of vitamin K (the amounts of vitamin K1 in the standard feed 
being limited and provided by the c reals incorporated). The latter recei ed virtually no vitamin K1 
a d, since there is no endoge ous sy thesis of v tamin K1, vitamin K1 was almost undetectable in rat 
tissues. Osteocalcin is a vitamin K-depe dent pr tein produced m stly by steoblasts [35]. In the 
absence of vitamin , the concentration of uc C increases rap dly in pla ma [36] and is, t erefore, 
considered a good marker of overall vitamin K status. Tissue calcium concentratio s have also been 
shown t  b egatively correlated with he vitamin K status. In the absence of vitamin K, MGP, which 
is another vitamin K- ependent protein, cannot be activat d d, herefore, cannot inhibit tissue 
calcificatio  [23,37,38]. 
Table 4. S mmary of the es lts obtained for each s rain comp red to the WT strain;  , decrease 
compared to WT st ain;  , increase for WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY
In liver    
In testis    
In kidney    
In lung   = 
VKO C1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
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being further away from the latte  [31]. se strai s were erived from the OFA-Sprague Dawley 
rat i  which t e mutated Vkorc1 ge e was in roduced with less than 0.0001% of the initial genome of 
th  wild brown ra . We can, thus, legitimately affect the phenotypic mo ifications to the Vkorc1 
utation. 
We first assessed the i pact of the mu ation o  t e ab lity of each tissue to recycle vitamin K. 
For this, we measure  VKOR activi  from l ver, kidney, lung, and testicular microsomes. VKORC1 
is localized in the membr ne of the endoplasmic reticulum [2]. The liver is responsible for the 
activation of factors II VII, IX, and X {2]. The kidney, lung, and testis contain high amounts of vitamin 
K [32] and calcify trongly in the ab ence of vitamin K [23]. Regardless f the tissue, microsomal 
VKOR activity is always grea ly decrease  when VKORC1 is mutated, regardless of the position (i.e., 
a ino acid 120 or a ino acid 139) an  ature (w ethe  amino acid 139 is rep ced by phenylalalanine 
or cystei e) of t e m tation. Affinity for v tamin K does not seem to be modified (Km unchanged), 
but velocit  of VKOR activity is system tically greatly reduced (by a factor of 3 to 6 depe ding on 
t e tissu  and the u atio ). This loss of v locity may be due to a malfunction of VKORC1 due to 
utatio s a d/or  decreas  in the VKORC1 xpressi n l vel because of instability of the mutated 
pro i s. The malfunction is tain. The c aracterization of the corresponding recombinant proteins 
has demonstrated this loss of v l city [33]. On the other and, this study shows that the VKORC1 
xpr sio level mains uncha ged d pite the pre e ce of mutations L120Q, Y139F, or Y139  
r gardless of the tissu , except in the liv r of the Y139F strain where VKORC1 is slightly expressed. 
Expression of VKORC1L1, w ich is another nzyme that is able t  catalyze VKOR activity [34] and, 
thus, ompensate for los  of VKORC1 activity, lso remains u change  exc p  in lungs where its 
expr ssion is slightly i creased o compensa e for the loss of activity of VKORC1 in the lung. 
T e presen e of these mutatio s in rats that can b  considered laboratory rats allowed us to 
a pr ciate th cons que ces of a decre se i  VKOR ctivity on the “vitamin K” status (Table 4). This 
status was evaluated by de er i ing ti su  vi ami  K conc ntrati ns, measurement of plasma ucOC 
co c ntration, and d termination of ti sue calcium l vels. Among the K vitamins, only MK4 was 
m asured because the rats used rece ved, from the ge of 3 weeks up to 8 weeks, a diet supplemented 
with menadi n  as their sole sourc  of vitamin K (the amounts of vitamin K1 in the standard feed 
b ing limited and provid d by th  cer als incorporated). The latter rece ved virtually no vitamin K1 
a d, sinc  there is no nd genous synthesis of vitamin K1, v tami  K1 w s almost undetectable in rat 
tis u s. Os eocalc is a vitamin K-depe dent pr tein produced m stly by osteoblasts [35]. In the 
bsenc of vitamin K, the once tration of ucOC increas s rap dly in plasma [36] and is, therefore, 
considered a good m rker of overall vitamin K status. Tis ue calcium concentrations have also been 
shown to be negatively correlated with the vitamin K status. In the absence of vitamin K, MGP, which 
is another vitamin K-depe dent protein, can ot be activa ed a d, therefore, cannot inhibit tissue 
calcificatio  [23,37,38]. 
Table 4. Summ ry f the results obtained for each strain compared to the WT strain;  , decrease 
compared to WT st ain;  , increase fo  WT strain; =, similar with WT strain. 
 L120Q Y139F Y139C 
VKOR ACTIVITY
In liver    
In testis    
In kidney    
In lung   = 
VKORC1 CONCENTRATION 
In liver =  = 
In testis = = = 
In kidney = = = 
In lung = = = 
VKORC1L1 CONCENTRATION 
In liver = = = 
TISSUE CALCIUM CONCENTRATION
In liver = = =
In testis = = =
In kidney = = =
In lung =
The modification of the vitamin K status in the mutated rat strains does not appear to have
apparent clinical consequences when animals receive a diet supplemented with menadione. In fact,
the rats do not show any changes in coagulation (the quick times are comparable between strains)
and do not seem to have calcification problems (tissue calcium concentrations are also comparable
between strains). On the other hand, it has been shown that rats homozygous for the Y139C mutation
receiving a synthetic diet (cereals replaced by starch) not supplemented with menadione for three
months presented very strong vascular calcifications in testes, lungs, and kidneys [23]. This is why
we evaluated the ability of different rat strains to resist a limited vitamin K intake by feeding them a
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synthetic diet without menadione (diet-K3) for a period of 12 days. To evaluate their resistance, we
determined tissue MK4 concentrations (except those in liver because of the extra low concentrations),
plasma ucOC concentrations, and prothrombin time, throughout the period of limited intake of vitamin
K. Menadione deficiency results very rapidly into lower tissue levels of MK4 in all tissues, regardless
of strains. After only four days of menadione deficiency, tissue MK4 concentrations are no longer
different between strains (except in testis of wild type rats). In the absence of menadione intake,
synthesis of MK4 by the enzyme UBIA1 is stopped [42,43] and tissue MK4 levels decrease to reach the
same concentration in all rats. The residual quantities are potentially synthesized by the intestinal
microflora [44], with the animals being all housed under the same breeding conditions, in the same
rooms, and receiving all the same food. It was discovered that the presence of MK4 in the testis of
wild type rats persisted longer. This persistence remains unexplained. The rapid decrease in testis
of mutated strains might be due to the needs of vitamin K in other tissues to maintain the pool of
activated VKDP.
This rapid decrease in MK4 concentrations is associated with a rapid increase in ucOC concentration
in all mutated rats. This increase is even more rapid in the homozygous rats for the L120Q mutation
with a concentration of ucOC becoming similar to that of rats homozygous for mutations Y139C and
Y139F from the fourth day after the beginning of the deficiency, whereas this concentration was initially
lower than that of rats homozygous for mutations Y139C and Y139F. The ucOC concentration remains
unchanged in wild type rats. The same findings had already been reported for MGP in the Y139C
rat with an increase in tissue ucMGP concentrations [23]. These evolutions are completely consistent
with the capacity of each strain to recycle vitamin K. Since dietary vitamin K intake is limited, the
gamma-carboxylation of vitamin K dependent proteins is dependent on the recycling of residual
concentrations of vitamin K. The wild type rat has optimal recycling and is virtually independent
of vitamin K dietary intakes. Mutated rats with limited recycling have high dietary vitamin K
requirements and, when vitamin K intake is reduced, activation of vitamin K-dependent proteins
becomes insufficient due to a lack of vitamin K quinone. Nevertheless, activation of hepatic vitamin
K-dependent proteins (i.e., coagulation factor II, VII IX, and X) appears to be relatively preserved
when compared to those of extrahepatic vitamin K dependent proteins (i.e., OC). The prothrombin
times remain unchanged throughout the 12 days of deficiency, (with the exception of those of rats
homozygous for the L120Q mutation which increase after 8 days of deficiency), whereas the ucOC
concentration increases from the fourth day of deficiency. Since the liver is the first organ to capture
dietary vitamin K, it is possible that vitamin K1 present in reduced amounts in food may maintain
activated clotting factor concentrations at levels consistent with a normal prothrombin time [45]. In rats
homozygous for the L120Q mutation, the recycling efficiency being the lowest (3 and 1.5 times lower
than the homozygous rats for the Y139F and Y139C mutation, respectively), the low dietary intake is
no longer sufficient to maintain the pools of activated clotting factors at sufficient levels.
In this study, we clearly showed that coding mutations of the Vkorc1 gene could affect the vitamin
K status due to failing vitamin K recycling. This change in the vitamin K status has no apparent clinical
consequences if vitamin K dietary intake is sufficient. In case of insufficient dietary vitamin K intake,
these mutations can lead to insufficient activation of extrahepatic vitamin K-dependent proteins that
can lead to vascular calcification due to the absence of MGP activation [23,46] changes in glucose
homeostasis due to the increase in plasma ucOC described as an osteoblast-derived hormone [47],
or even coagulation problems in the case of mutations severely affecting the efficiency of vitamin K
recycling. Nevertheless, during this study, only three mutations were characterized. The three mutated
amino acids are all localized in the fourth transmembrane domain containing the catalytic site [31],
whereas, in humans, mutations have been detected in the four transmembrane domains and in the
cytosolic loop and do not always seem to affect VKORC1 activity [30]. Further studies will be needed
to evaluate the impact of each mutation on the vitamin K status. Nevertheless, the prevalence of these
mutations in patients with vascular calcifications could be informative with regard to their impact on
vitamin K status.
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